id	sid	tid	token	lemma	pos
ajlm-1355	1	1	abstract	abstract	ADJ
ajlm-1355	1	2	introduction	introduction	NOUN
ajlm-1355	1	3	ethical	ethical	ADJ
ajlm-1355	1	4	considerations	consideration	NOUN
ajlm-1355	1	5	case	case	NOUN
ajlm-1355	1	6	presentation	presentation	NOUN
ajlm-1355	1	7	management	management	NOUN
ajlm-1355	1	8	and	and	CCONJ
ajlm-1355	1	9	outcomes	outcome	NOUN
ajlm-1355	1	10	discussion	discussion	NOUN
ajlm-1355	1	11	acknowledgements	acknowledgement	NOUN
ajlm-1355	1	12	references	reference	NOUN
ajlm-1355	1	13	about	about	ADP
ajlm-1355	1	14	the	the	DET
ajlm-1355	1	15	author(s	author(s	NOUN
ajlm-1355	1	16	)	)	PUNCT
ajlm-1355	1	17	katherine	katherine	PROPN
ajlm-1355	1	18	e.	e.	PROPN
ajlm-1355	1	19	hodkinson	hodkinson	PROPN
ajlm-1355	1	20	department	department	PROPN
ajlm-1355	1	21	of	of	ADP
ajlm-1355	1	22	molecular	molecular	ADJ
ajlm-1355	1	23	medicine	medicine	NOUN
ajlm-1355	1	24	and	and	CCONJ
ajlm-1355	1	25	haematology	haematology	NOUN
ajlm-1355	1	26	,	,	PUNCT
ajlm-1355	1	27	university	university	NOUN
ajlm-1355	1	28	of	of	ADP
ajlm-1355	1	29	the	the	DET
ajlm-1355	1	30	witwatersrand	witwatersrand	NOUN
ajlm-1355	1	31	,	,	PUNCT
ajlm-1355	1	32	johannesburg	johannesburg	PROPN
ajlm-1355	1	33	,	,	PUNCT
ajlm-1355	1	34	south	south	PROPN
ajlm-1355	1	35	africa	africa	PROPN
ajlm-1355	1	36	national	national	PROPN
ajlm-1355	1	37	health	health	PROPN
ajlm-1355	1	38	laboratory	laboratory	PROPN
ajlm-1355	1	39	services	services	PROPN
ajlm-1355	1	40	,	,	PUNCT
ajlm-1355	1	41	johannesburg	johannesburg	PROPN
ajlm-1355	1	42	,	,	PUNCT
ajlm-1355	1	43	south	south	PROPN
ajlm-1355	1	44	africa	africa	PROPN
ajlm-1355	1	45	yvonne	yvonne	PROPN
ajlm-1355	1	46	perner	perner	PROPN
ajlm-1355	1	47	national	national	PROPN
ajlm-1355	1	48	health	health	PROPN
ajlm-1355	1	49	laboratory	laboratory	PROPN
ajlm-1355	1	50	services	services	PROPN
ajlm-1355	1	51	,	,	PUNCT
ajlm-1355	1	52	johannesburg	johannesburg	PROPN
ajlm-1355	1	53	,	,	PUNCT
ajlm-1355	1	54	south	south	PROPN
ajlm-1355	1	55	africa	africa	PROPN
ajlm-1355	1	56	department	department	PROPN
ajlm-1355	1	57	of	of	ADP
ajlm-1355	1	58	anatomical	anatomical	ADJ
ajlm-1355	1	59	pathology	pathology	NOUN
ajlm-1355	1	60	,	,	PUNCT
ajlm-1355	1	61	university	university	NOUN
ajlm-1355	1	62	of	of	ADP
ajlm-1355	1	63	the	the	DET
ajlm-1355	1	64	witwatersrand	witwatersrand	NOUN
ajlm-1355	1	65	,	,	PUNCT
ajlm-1355	1	66	johannesburg	johannesburg	PROPN
ajlm-1355	1	67	,	,	PUNCT
ajlm-1355	1	68	south	south	PROPN
ajlm-1355	1	69	africa	africa	PROPN
ajlm-1355	1	70	deborah	deborah	PROPN
ajlm-1355	1	71	k.	k.	PROPN
ajlm-1355	2	1	glencross	glencross	PROPN
ajlm-1355	2	2	national	national	PROPN
ajlm-1355	2	3	health	health	PROPN
ajlm-1355	2	4	laboratory	laboratory	PROPN
ajlm-1355	2	5	services	services	PROPN
ajlm-1355	2	6	,	,	PUNCT
ajlm-1355	2	7	johannesburg	johannesburg	PROPN
ajlm-1355	2	8	,	,	PUNCT
ajlm-1355	2	9	south	south	PROPN
ajlm-1355	2	10	africa	africa	PROPN
ajlm-1355	2	11	department	department	PROPN
ajlm-1355	2	12	of	of	ADP
ajlm-1355	2	13	haematology	haematology	NOUN
ajlm-1355	2	14	and	and	CCONJ
ajlm-1355	2	15	molecular	molecular	ADJ
ajlm-1355	2	16	medicine	medicine	NOUN
ajlm-1355	2	17	,	,	PUNCT
ajlm-1355	2	18	university	university	NOUN
ajlm-1355	2	19	of	of	ADP
ajlm-1355	2	20	the	the	DET
ajlm-1355	2	21	witwatersrand	witwatersrand	NOUN
ajlm-1355	2	22	,	,	PUNCT
ajlm-1355	2	23	johannesburg	johannesburg	PROPN
ajlm-1355	2	24	,	,	PUNCT
ajlm-1355	2	25	south	south	PROPN
ajlm-1355	2	26	africa	africa	PROPN
ajlm-1355	2	27	tracey	tracey	PROPN
ajlm-1355	2	28	wiggill	wiggill	PROPN
ajlm-1355	2	29	national	national	PROPN
ajlm-1355	2	30	health	health	PROPN
ajlm-1355	2	31	laboratory	laboratory	PROPN
ajlm-1355	2	32	services	services	PROPN
ajlm-1355	2	33	,	,	PUNCT
ajlm-1355	2	34	johannesburg	johannesburg	PROPN
ajlm-1355	2	35	,	,	PUNCT
ajlm-1355	2	36	south	south	PROPN
ajlm-1355	2	37	africa	africa	PROPN
ajlm-1355	2	38	department	department	PROPN
ajlm-1355	2	39	of	of	ADP
ajlm-1355	2	40	haematology	haematology	NOUN
ajlm-1355	2	41	and	and	CCONJ
ajlm-1355	2	42	molecular	molecular	ADJ
ajlm-1355	2	43	medicine	medicine	NOUN
ajlm-1355	2	44	,	,	PUNCT
ajlm-1355	2	45	university	university	NOUN
ajlm-1355	2	46	of	of	ADP
ajlm-1355	2	47	the	the	DET
ajlm-1355	2	48	witwatersrand	witwatersrand	NOUN
ajlm-1355	2	49	,	,	PUNCT
ajlm-1355	2	50	johannesburg	johannesburg	PROPN
ajlm-1355	2	51	,	,	PUNCT
ajlm-1355	2	52	south	south	PROPN
ajlm-1355	2	53	africa	africa	PROPN
ajlm-1355	2	54	adam	adam	PROPN
ajlm-1355	2	55	botha	botha	PROPN
ajlm-1355	2	56	national	national	PROPN
ajlm-1355	2	57	health	health	PROPN
ajlm-1355	2	58	laboratory	laboratory	PROPN
ajlm-1355	2	59	services	services	PROPN
ajlm-1355	2	60	,	,	PUNCT
ajlm-1355	2	61	johannesburg	johannesburg	PROPN
ajlm-1355	2	62	,	,	PUNCT
ajlm-1355	2	63	south	south	PROPN
ajlm-1355	2	64	africa	africa	PROPN
ajlm-1355	2	65	department	department	PROPN
ajlm-1355	2	66	of	of	ADP
ajlm-1355	2	67	anatomical	anatomical	ADJ
ajlm-1355	2	68	pathology	pathology	NOUN
ajlm-1355	2	69	,	,	PUNCT
ajlm-1355	2	70	university	university	NOUN
ajlm-1355	2	71	of	of	ADP
ajlm-1355	2	72	the	the	DET
ajlm-1355	2	73	witwatersrand	witwatersrand	NOUN
ajlm-1355	2	74	,	,	PUNCT
ajlm-1355	2	75	johannesburg	johannesburg	PROPN
ajlm-1355	2	76	,	,	PUNCT
ajlm-1355	2	77	south	south	PROPN
ajlm-1355	2	78	africa	africa	PROPN
ajlm-1355	2	79	janet	janet	PROPN
ajlm-1355	2	80	poole	poole	PROPN
ajlm-1355	2	81	department	department	PROPN
ajlm-1355	2	82	of	of	ADP
ajlm-1355	2	83	paediatric	paediatric	ADJ
ajlm-1355	2	84	oncology	oncology	NOUN
ajlm-1355	2	85	,	,	PUNCT
ajlm-1355	2	86	university	university	NOUN
ajlm-1355	2	87	of	of	ADP
ajlm-1355	2	88	the	the	DET
ajlm-1355	2	89	witwatersrand	witwatersrand	NOUN
ajlm-1355	2	90	,	,	PUNCT
ajlm-1355	2	91	johannesburg	johannesburg	PROPN
ajlm-1355	2	92	,	,	PUNCT
ajlm-1355	2	93	south	south	PROPN
ajlm-1355	2	94	africa	africa	PROPN
ajlm-1355	2	95	department	department	PROPN
ajlm-1355	2	96	of	of	ADP
ajlm-1355	2	97	paediatric	paediatric	ADJ
ajlm-1355	2	98	oncology	oncology	NOUN
ajlm-1355	2	99	,	,	PUNCT
ajlm-1355	2	100	charlotte	charlotte	PROPN
ajlm-1355	2	101	maxeke	maxeke	PROPN
ajlm-1355	2	102	johannesburg	johannesburg	PROPN
ajlm-1355	2	103	academic	academic	PROPN
ajlm-1355	2	104	hospital	hospital	PROPN
ajlm-1355	2	105	,	,	PUNCT
ajlm-1355	2	106	johannesburg	johannesburg	PROPN
ajlm-1355	2	107	,	,	PUNCT
ajlm-1355	2	108	south	south	PROPN
ajlm-1355	2	109	africa	africa	PROPN
ajlm-1355	2	110	citation	citation	PROPN
ajlm-1355	2	111	hodkinson	hodkinson	PROPN
ajlm-1355	2	112	ke	ke	PROPN
ajlm-1355	2	113	,	,	PUNCT
ajlm-1355	2	114	perner	perner	NOUN
ajlm-1355	2	115	y	y	PROPN
ajlm-1355	2	116	,	,	PUNCT
ajlm-1355	2	117	glencross	glencross	ADJ
ajlm-1355	2	118	dk	dk	PROPN
ajlm-1355	2	119	,	,	PUNCT
ajlm-1355	2	120	wiggill	wiggill	PROPN
ajlm-1355	2	121	t	t	PROPN
ajlm-1355	2	122	,	,	PUNCT
ajlm-1355	2	123	botha	botha	PROPN
ajlm-1355	2	124	a	a	DET
ajlm-1355	2	125	,	,	PUNCT
ajlm-1355	2	126	poole	poole	PROPN
ajlm-1355	2	127	j.	j.	PROPN
ajlm-1355	2	128	extranodal	extranodal	PROPN
ajlm-1355	2	129	presentation	presentation	NOUN
ajlm-1355	2	130	of	of	ADP
ajlm-1355	2	131	a	a	DET
ajlm-1355	2	132	lymphoma	lymphoma	NOUN
ajlm-1355	2	133	with	with	ADP
ajlm-1355	2	134	precursor	precursor	NOUN
ajlm-1355	2	135	b	b	NOUN
ajlm-1355	2	136	-	-	PUNCT
ajlm-1355	2	137	cell	cell	NOUN
ajlm-1355	2	138	phenotype	phenotype	NOUN
ajlm-1355	2	139	and	and	CCONJ
ajlm-1355	2	140	translocation	translocation	NOUN
ajlm-1355	2	141	t(8;14	t(8;14	PROPN
ajlm-1355	2	142	)	)	PUNCT
ajlm-1355	2	143	in	in	ADP
ajlm-1355	2	144	south	south	PROPN
ajlm-1355	2	145	africa	africa	PROPN
ajlm-1355	2	146	.	.	PUNCT
ajlm-1355	3	1	afr	afr	PROPN
ajlm-1355	3	2	j	j	PROPN
ajlm-1355	3	3	lab	lab	PROPN
ajlm-1355	3	4	med	med	PROPN
ajlm-1355	3	5	.	.	PUNCT
ajlm-1355	4	1	2022;11(1	2022;11(1	NUM
ajlm-1355	4	2	)	)	PUNCT
ajlm-1355	4	3	,	,	PUNCT
ajlm-1355	5	1	a1355	a1355	PROPN
ajlm-1355	5	2	.	.	PUNCT
ajlm-1355	5	3	https://doi.org/10.4102/ajlm.v11i1.1355	https://doi.org/10.4102/ajlm.v11i1.1355	PUNCT
ajlm-1355	5	4	case	case	NOUN
ajlm-1355	5	5	study	study	NOUN
ajlm-1355	5	6	extranodal	extranodal	NOUN
ajlm-1355	5	7	presentation	presentation	NOUN
ajlm-1355	5	8	of	of	ADP
ajlm-1355	5	9	a	a	DET
ajlm-1355	5	10	lymphoma	lymphoma	NOUN
ajlm-1355	5	11	with	with	ADP
ajlm-1355	5	12	precursor	precursor	NOUN
ajlm-1355	5	13	b	b	NOUN
ajlm-1355	5	14	-	-	PUNCT
ajlm-1355	5	15	cell	cell	NOUN
ajlm-1355	5	16	phenotype	phenotype	NOUN
ajlm-1355	5	17	and	and	CCONJ
ajlm-1355	5	18	translocation	translocation	NOUN
ajlm-1355	5	19	t(8;14	t(8;14	PROPN
ajlm-1355	5	20	)	)	PUNCT
ajlm-1355	5	21	in	in	ADP
ajlm-1355	5	22	south	south	PROPN
ajlm-1355	5	23	africa	africa	PROPN
ajlm-1355	5	24	katherine	katherine	PROPN
ajlm-1355	5	25	e.	e.	PROPN
ajlm-1355	5	26	hodkinson	hodkinson	PROPN
ajlm-1355	5	27	,	,	PUNCT
ajlm-1355	5	28	yvonne	yvonne	PROPN
ajlm-1355	5	29	perner	perner	PROPN
ajlm-1355	5	30	,	,	PUNCT
ajlm-1355	5	31	deborah	deborah	PROPN
ajlm-1355	5	32	k.	k.	PROPN
ajlm-1355	5	33	glencross	glencross	PROPN
ajlm-1355	5	34	,	,	PUNCT
ajlm-1355	5	35	tracey	tracey	PROPN
ajlm-1355	5	36	wiggill	wiggill	PROPN
ajlm-1355	5	37	,	,	PUNCT
ajlm-1355	5	38	adam	adam	PROPN
ajlm-1355	5	39	botha	botha	PROPN
ajlm-1355	5	40	,	,	PUNCT
ajlm-1355	5	41	janet	janet	PROPN
ajlm-1355	5	42	poole	poole	PROPN
ajlm-1355	5	43	received	receive	VERB
ajlm-1355	5	44	:	:	PUNCT
ajlm-1355	5	45	12	12	NUM
ajlm-1355	5	46	aug	aug	NOUN
ajlm-1355	5	47	.	.	PROPN
ajlm-1355	5	48	2020	2020	NUM
ajlm-1355	5	49	;	;	PUNCT
ajlm-1355	5	50	accepted	accept	VERB
ajlm-1355	5	51	:	:	PUNCT
ajlm-1355	5	52	14	14	NUM
ajlm-1355	5	53	sept	sept	PROPN
ajlm-1355	5	54	.	.	PROPN
ajlm-1355	5	55	2021	2021	NUM
ajlm-1355	5	56	;	;	PUNCT
ajlm-1355	5	57	published	publish	VERB
ajlm-1355	5	58	:	:	PUNCT
ajlm-1355	5	59	31	31	NUM
ajlm-1355	5	60	jan	jan	PROPN
ajlm-1355	5	61	.	.	PROPN
ajlm-1355	6	1	2022	2022	NUM
ajlm-1355	6	2	copyright	copyright	NOUN
ajlm-1355	6	3	:	:	PUNCT
ajlm-1355	6	4	©	©	PROPN
ajlm-1355	6	5	2022	2022	NUM
ajlm-1355	6	6	.	.	PUNCT
ajlm-1355	7	1	the	the	DET
ajlm-1355	7	2	author(s	author(s	PROPN
ajlm-1355	7	3	)	)	PUNCT
ajlm-1355	7	4	.	.	PUNCT
ajlm-1355	8	1	licensee	licensee	NOUN
ajlm-1355	8	2	:	:	PUNCT
ajlm-1355	8	3	aosis	aosis	NOUN
ajlm-1355	8	4	.	.	PUNCT
ajlm-1355	9	1	this	this	PRON
ajlm-1355	9	2	is	be	AUX
ajlm-1355	9	3	an	an	DET
ajlm-1355	9	4	open	open	ADJ
ajlm-1355	9	5	access	access	NOUN
ajlm-1355	9	6	article	article	NOUN
ajlm-1355	9	7	distributed	distribute	VERB
ajlm-1355	9	8	under	under	ADP
ajlm-1355	9	9	the	the	DET
ajlm-1355	9	10	terms	term	NOUN
ajlm-1355	9	11	of	of	ADP
ajlm-1355	9	12	the	the	DET
ajlm-1355	9	13	creative	creative	ADJ
ajlm-1355	9	14	commons	common	NOUN
ajlm-1355	9	15	attribution	attribution	NOUN
ajlm-1355	9	16	license	license	NOUN
ajlm-1355	9	17	,	,	PUNCT
ajlm-1355	9	18	which	which	PRON
ajlm-1355	9	19	permits	permit	VERB
ajlm-1355	9	20	unrestricted	unrestricted	ADJ
ajlm-1355	9	21	use	use	NOUN
ajlm-1355	9	22	,	,	PUNCT
ajlm-1355	9	23	distribution	distribution	NOUN
ajlm-1355	9	24	,	,	PUNCT
ajlm-1355	9	25	and	and	CCONJ
ajlm-1355	9	26	reproduction	reproduction	NOUN
ajlm-1355	9	27	in	in	ADP
ajlm-1355	9	28	any	any	DET
ajlm-1355	9	29	medium	medium	NOUN
ajlm-1355	9	30	,	,	PUNCT
ajlm-1355	9	31	provided	provide	VERB
ajlm-1355	9	32	the	the	DET
ajlm-1355	9	33	original	original	ADJ
ajlm-1355	9	34	work	work	NOUN
ajlm-1355	9	35	is	be	AUX
ajlm-1355	9	36	properly	properly	ADV
ajlm-1355	9	37	cited	cite	VERB
ajlm-1355	9	38	.	.	PUNCT
ajlm-1355	10	1	abstract	abstract	ADJ
ajlm-1355	10	2	introduction	introduction	NOUN
ajlm-1355	10	3	:	:	PUNCT
ajlm-1355	10	4	a	a	DET
ajlm-1355	10	5	rare	rare	ADJ
ajlm-1355	10	6	entity	entity	NOUN
ajlm-1355	10	7	of	of	ADP
ajlm-1355	10	8	a	a	DET
ajlm-1355	10	9	b	b	NOUN
ajlm-1355	10	10	-	-	PUNCT
ajlm-1355	10	11	cell	cell	NOUN
ajlm-1355	10	12	malignancy	malignancy	NOUN
ajlm-1355	10	13	with	with	ADP
ajlm-1355	10	14	precursor	precursor	NOUN
ajlm-1355	10	15	b	b	NOUN
ajlm-1355	10	16	-	-	PUNCT
ajlm-1355	10	17	cell	cell	NOUN
ajlm-1355	10	18	phenotype	phenotype	NOUN
ajlm-1355	10	19	and	and	CCONJ
ajlm-1355	10	20	concomitant	concomitant	ADJ
ajlm-1355	10	21	translocation	translocation	NOUN
ajlm-1355	10	22	t(8;14	t(8;14	PROPN
ajlm-1355	10	23	)	)	PUNCT
ajlm-1355	10	24	or	or	CCONJ
ajlm-1355	10	25	variant	variant	NOUN
ajlm-1355	10	26	myc	myc	NOUN
ajlm-1355	10	27	translocation	translocation	NOUN
ajlm-1355	10	28	exists	exist	VERB
ajlm-1355	10	29	.	.	PUNCT
ajlm-1355	11	1	these	these	DET
ajlm-1355	11	2	cases	case	NOUN
ajlm-1355	11	3	show	show	VERB
ajlm-1355	11	4	clinical	clinical	ADJ
ajlm-1355	11	5	,	,	PUNCT
ajlm-1355	11	6	pathological	pathological	ADJ
ajlm-1355	11	7	and	and	CCONJ
ajlm-1355	11	8	molecular	molecular	ADJ
ajlm-1355	11	9	overlap	overlap	NOUN
ajlm-1355	11	10	between	between	ADP
ajlm-1355	11	11	precursor	precursor	NOUN
ajlm-1355	11	12	b	b	NOUN
ajlm-1355	11	13	-	-	PUNCT
ajlm-1355	11	14	lymphoblastic	lymphoblastic	ADJ
ajlm-1355	11	15	leukaemia	leukaemia	NOUN
ajlm-1355	11	16	or	or	CCONJ
ajlm-1355	11	17	lymphoma	lymphoma	NOUN
ajlm-1355	11	18	and	and	CCONJ
ajlm-1355	11	19	burkitt	burkitt	PROPN
ajlm-1355	11	20	leukaemia	leukaemia	NOUN
ajlm-1355	11	21	or	or	CCONJ
ajlm-1355	11	22	lymphoma	lymphoma	NOUN
ajlm-1355	11	23	(	(	PUNCT
ajlm-1355	11	24	bll	bll	PROPN
ajlm-1355	11	25	)	)	PUNCT
ajlm-1355	11	26	.	.	PUNCT
ajlm-1355	12	1	case	case	NOUN
ajlm-1355	12	2	presentation	presentation	NOUN
ajlm-1355	12	3	:	:	PUNCT
ajlm-1355	12	4	we	we	PRON
ajlm-1355	12	5	report	report	VERB
ajlm-1355	12	6	a	a	DET
ajlm-1355	12	7	case	case	NOUN
ajlm-1355	12	8	from	from	ADP
ajlm-1355	12	9	february	february	PROPN
ajlm-1355	12	10	2019	2019	NUM
ajlm-1355	12	11	at	at	ADP
ajlm-1355	12	12	the	the	DET
ajlm-1355	12	13	charlotte	charlotte	PROPN
ajlm-1355	12	14	maxeke	maxeke	PROPN
ajlm-1355	12	15	johannesburg	johannesburg	PROPN
ajlm-1355	12	16	academic	academic	ADJ
ajlm-1355	12	17	hospital	hospital	PROPN
ajlm-1355	12	18	,	,	PUNCT
ajlm-1355	12	19	south	south	PROPN
ajlm-1355	12	20	africa	africa	PROPN
ajlm-1355	12	21	,	,	PUNCT
ajlm-1355	12	22	of	of	ADP
ajlm-1355	12	23	a	a	DET
ajlm-1355	12	24	9	9	NUM
ajlm-1355	12	25	-	-	PUNCT
ajlm-1355	12	26	month	month	NOUN
ajlm-1355	12	27	-	-	PUNCT
ajlm-1355	12	28	old	old	ADJ
ajlm-1355	12	29	infant	infant	NOUN
ajlm-1355	12	30	with	with	ADP
ajlm-1355	12	31	a	a	DET
ajlm-1355	12	32	predominantly	predominantly	ADV
ajlm-1355	12	33	extracranial	extracranial	ADJ
ajlm-1355	12	34	soft	soft	ADJ
ajlm-1355	12	35	tissue	tissue	NOUN
ajlm-1355	12	36	mass	mass	NOUN
ajlm-1355	12	37	showing	show	VERB
ajlm-1355	12	38	extradural	extradural	ADJ
ajlm-1355	12	39	extension	extension	NOUN
ajlm-1355	12	40	.	.	PUNCT
ajlm-1355	13	1	there	there	PRON
ajlm-1355	13	2	was	be	VERB
ajlm-1355	13	3	no	no	DET
ajlm-1355	13	4	involvement	involvement	NOUN
ajlm-1355	13	5	of	of	ADP
ajlm-1355	13	6	the	the	DET
ajlm-1355	13	7	peripheral	peripheral	ADJ
ajlm-1355	13	8	blood	blood	NOUN
ajlm-1355	13	9	or	or	CCONJ
ajlm-1355	13	10	bone	bone	NOUN
ajlm-1355	13	11	marrow	marrow	NOUN
ajlm-1355	13	12	.	.	PUNCT
ajlm-1355	14	1	fine	fine	ADJ
ajlm-1355	14	2	needle	needle	NOUN
ajlm-1355	14	3	aspiration	aspiration	NOUN
ajlm-1355	14	4	and	and	CCONJ
ajlm-1355	14	5	tru	tru	NOUN
ajlm-1355	14	6	-	-	PUNCT
ajlm-1355	14	7	cut	cut	VERB
ajlm-1355	14	8	biopsy	biopsy	NOUN
ajlm-1355	14	9	of	of	ADP
ajlm-1355	14	10	the	the	DET
ajlm-1355	14	11	soft	soft	ADJ
ajlm-1355	14	12	tissue	tissue	NOUN
ajlm-1355	14	13	scalp	scalp	NOUN
ajlm-1355	14	14	mass	mass	PROPN
ajlm-1355	14	15	showed	show	VERB
ajlm-1355	14	16	the	the	DET
ajlm-1355	14	17	tumour	tumour	NOUN
ajlm-1355	14	18	to	to	PART
ajlm-1355	14	19	be	be	AUX
ajlm-1355	14	20	of	of	ADP
ajlm-1355	14	21	precursor	precursor	NOUN
ajlm-1355	14	22	b	b	NOUN
ajlm-1355	14	23	-	-	PUNCT
ajlm-1355	14	24	cell	cell	NOUN
ajlm-1355	14	25	phenotype	phenotype	NOUN
ajlm-1355	14	26	.	.	PUNCT
ajlm-1355	15	1	contrastingly	contrastingly	ADV
ajlm-1355	15	2	,	,	PUNCT
ajlm-1355	15	3	an	an	DET
ajlm-1355	15	4	immunophenotypic	immunophenotypic	ADJ
ajlm-1355	15	5	assessment	assessment	NOUN
ajlm-1355	15	6	revealed	reveal	VERB
ajlm-1355	15	7	a	a	DET
ajlm-1355	15	8	high	high	ADJ
ajlm-1355	15	9	s	s	NOUN
ajlm-1355	15	10	-	-	PUNCT
ajlm-1355	15	11	phase	phase	NOUN
ajlm-1355	15	12	fraction	fraction	NOUN
ajlm-1355	15	13	and	and	CCONJ
ajlm-1355	15	14	raised	raise	VERB
ajlm-1355	15	15	concern	concern	NOUN
ajlm-1355	15	16	for	for	ADP
ajlm-1355	15	17	bll	bll	PROPN
ajlm-1355	15	18	.	.	PUNCT
ajlm-1355	16	1	this	this	PRON
ajlm-1355	16	2	prompted	prompt	VERB
ajlm-1355	16	3	testing	testing	NOUN
ajlm-1355	16	4	for	for	ADP
ajlm-1355	16	5	the	the	DET
ajlm-1355	16	6	translocation	translocation	NOUN
ajlm-1355	16	7	t(8;14	t(8;14	PROPN
ajlm-1355	16	8	)	)	PUNCT
ajlm-1355	16	9	by	by	ADP
ajlm-1355	16	10	fluorescence	fluorescence	NOUN
ajlm-1355	16	11	in	in	ADP
ajlm-1355	16	12	-	-	PUNCT
ajlm-1355	16	13	situ	situ	ADJ
ajlm-1355	16	14	hybridisation	hybridisation	NOUN
ajlm-1355	16	15	analysis	analysis	NOUN
ajlm-1355	16	16	,	,	PUNCT
ajlm-1355	16	17	which	which	PRON
ajlm-1355	16	18	confirmed	confirm	VERB
ajlm-1355	16	19	this	this	DET
ajlm-1355	16	20	aberration	aberration	NOUN
ajlm-1355	16	21	.	.	PUNCT
ajlm-1355	17	1	management	management	NOUN
ajlm-1355	17	2	and	and	CCONJ
ajlm-1355	17	3	outcome	outcome	NOUN
ajlm-1355	17	4	:	:	PUNCT
ajlm-1355	17	5	based	base	VERB
ajlm-1355	17	6	on	on	ADP
ajlm-1355	17	7	the	the	DET
ajlm-1355	17	8	published	publish	VERB
ajlm-1355	17	9	experience	experience	NOUN
ajlm-1355	17	10	of	of	ADP
ajlm-1355	17	11	other	other	ADJ
ajlm-1355	17	12	centres	centre	NOUN
ajlm-1355	17	13	,	,	PUNCT
ajlm-1355	17	14	the	the	DET
ajlm-1355	17	15	patient	patient	NOUN
ajlm-1355	17	16	was	be	AUX
ajlm-1355	17	17	initiated	initiate	VERB
ajlm-1355	17	18	on	on	ADP
ajlm-1355	17	19	a	a	DET
ajlm-1355	17	20	bll	bll	PROPN
ajlm-1355	17	21	protocol	protocol	NOUN
ajlm-1355	17	22	.	.	PUNCT
ajlm-1355	18	1	despite	despite	SCONJ
ajlm-1355	18	2	an	an	DET
ajlm-1355	18	3	excellent	excellent	ADJ
ajlm-1355	18	4	clinical	clinical	ADJ
ajlm-1355	18	5	response	response	NOUN
ajlm-1355	18	6	,	,	PUNCT
ajlm-1355	18	7	the	the	DET
ajlm-1355	18	8	patient	patient	NOUN
ajlm-1355	18	9	succumbed	succumb	VERB
ajlm-1355	18	10	to	to	ADP
ajlm-1355	18	11	neutropenic	neutropenic	ADJ
ajlm-1355	18	12	sepsis	sepsis	NOUN
ajlm-1355	18	13	six	six	NUM
ajlm-1355	18	14	months	month	NOUN
ajlm-1355	18	15	after	after	ADP
ajlm-1355	18	16	diagnosis	diagnosis	NOUN
ajlm-1355	18	17	.	.	PUNCT
ajlm-1355	19	1	conclusion	conclusion	NOUN
ajlm-1355	19	2	:	:	PUNCT
ajlm-1355	19	3	leukaemia	leukaemia	NOUN
ajlm-1355	19	4	or	or	CCONJ
ajlm-1355	19	5	lymphoma	lymphoma	VERB
ajlm-1355	19	6	with	with	ADP
ajlm-1355	19	7	translocation	translocation	NOUN
ajlm-1355	19	8	t(8;14	t(8;14	PROPN
ajlm-1355	19	9	)	)	PUNCT
ajlm-1355	19	10	or	or	CCONJ
ajlm-1355	19	11	variant	variant	NOUN
ajlm-1355	19	12	myc	myc	NOUN
ajlm-1355	19	13	translocation	translocation	NOUN
ajlm-1355	19	14	and	and	CCONJ
ajlm-1355	19	15	precursor	precursor	NOUN
ajlm-1355	19	16	b	b	NOUN
ajlm-1355	19	17	-	-	PUNCT
ajlm-1355	19	18	cell	cell	NOUN
ajlm-1355	19	19	phenotype	phenotype	NOUN
ajlm-1355	19	20	is	be	AUX
ajlm-1355	19	21	a	a	DET
ajlm-1355	19	22	rare	rare	ADJ
ajlm-1355	19	23	entity	entity	NOUN
ajlm-1355	19	24	with	with	ADP
ajlm-1355	19	25	a	a	DET
ajlm-1355	19	26	varied	varied	ADJ
ajlm-1355	19	27	clinical	clinical	ADJ
ajlm-1355	19	28	presentation	presentation	NOUN
ajlm-1355	19	29	.	.	PUNCT
ajlm-1355	20	1	this	this	PRON
ajlm-1355	20	2	poses	pose	VERB
ajlm-1355	20	3	a	a	DET
ajlm-1355	20	4	challenge	challenge	NOUN
ajlm-1355	20	5	for	for	ADP
ajlm-1355	20	6	diagnosis	diagnosis	NOUN
ajlm-1355	20	7	and	and	CCONJ
ajlm-1355	20	8	classification	classification	NOUN
ajlm-1355	20	9	and	and	CCONJ
ajlm-1355	20	10	a	a	DET
ajlm-1355	20	11	clinical	clinical	ADJ
ajlm-1355	20	12	dilemma	dilemma	NOUN
ajlm-1355	20	13	for	for	ADP
ajlm-1355	20	14	the	the	DET
ajlm-1355	20	15	choice	choice	NOUN
ajlm-1355	20	16	of	of	ADP
ajlm-1355	20	17	treatment	treatment	NOUN
ajlm-1355	20	18	.	.	PUNCT
ajlm-1355	21	1	keywords	keyword	NOUN
ajlm-1355	21	2	:	:	PUNCT
ajlm-1355	21	3	burkitt	burkitt	PROPN
ajlm-1355	21	4	leukaemia	leukaemia	NOUN
ajlm-1355	21	5	/	/	SYM
ajlm-1355	21	6	lymphoma	lymphoma	NOUN
ajlm-1355	21	7	;	;	PUNCT
ajlm-1355	21	8	b	b	X
ajlm-1355	21	9	-	-	PUNCT
ajlm-1355	21	10	lymphoblastic	lymphoblastic	ADJ
ajlm-1355	21	11	leukaemia	leukaemia	NOUN
ajlm-1355	21	12	/	/	SYM
ajlm-1355	21	13	lymphoma	lymphoma	NOUN
ajlm-1355	21	14	;	;	PUNCT
ajlm-1355	21	15	translocation	translocation	NOUN
ajlm-1355	21	16	t(8;14	t(8;14	PROPN
ajlm-1355	21	17	)	)	PUNCT
ajlm-1355	21	18	;	;	PUNCT
ajlm-1355	21	19	variant	variant	NOUN
ajlm-1355	21	20	myc	myc	NOUN
ajlm-1355	21	21	translocations	translocation	NOUN
ajlm-1355	21	22	;	;	PUNCT
ajlm-1355	21	23	s	s	X
ajlm-1355	21	24	-	-	PUNCT
ajlm-1355	21	25	phase	phase	NOUN
ajlm-1355	21	26	fraction	fraction	NOUN
ajlm-1355	21	27	;	;	PUNCT
ajlm-1355	21	28	terminal	terminal	ADJ
ajlm-1355	21	29	deoxynucleotidyl	deoxynucleotidyl	NOUN
ajlm-1355	21	30	transferase	transferase	NOUN
ajlm-1355	21	31	(	(	PUNCT
ajlm-1355	21	32	tdt	tdt	PROPN
ajlm-1355	21	33	)	)	PUNCT
ajlm-1355	21	34	;	;	PUNCT
ajlm-1355	21	35	extranodal	extranodal	NOUN
ajlm-1355	21	36	.	.	PUNCT
ajlm-1355	22	1	introduction	introduction	NOUN
ajlm-1355	22	2	the	the	DET
ajlm-1355	22	3	presence	presence	NOUN
ajlm-1355	22	4	of	of	ADP
ajlm-1355	22	5	the	the	DET
ajlm-1355	22	6	translocation	translocation	NOUN
ajlm-1355	22	7	t(8;14	t(8;14	NOUN
ajlm-1355	22	8	)	)	PUNCT
ajlm-1355	22	9	or	or	CCONJ
ajlm-1355	22	10	variant	variant	ADJ
ajlm-1355	22	11	myc	myc	NOUN
ajlm-1355	22	12	translocation	translocation	NOUN
ajlm-1355	22	13	in	in	ADP
ajlm-1355	22	14	leukaemia	leukaemia	NOUN
ajlm-1355	22	15	with	with	ADP
ajlm-1355	22	16	a	a	DET
ajlm-1355	22	17	precursor	precursor	NOUN
ajlm-1355	22	18	b	b	NOUN
ajlm-1355	22	19	-	-	PUNCT
ajlm-1355	22	20	cell	cell	NOUN
ajlm-1355	22	21	phenotype	phenotype	NOUN
ajlm-1355	22	22	has	have	AUX
ajlm-1355	22	23	been	be	AUX
ajlm-1355	22	24	described	describe	VERB
ajlm-1355	22	25	in	in	ADP
ajlm-1355	22	26	approximately	approximately	ADV
ajlm-1355	22	27	2	2	NUM
ajlm-1355	22	28	%	%	NOUN
ajlm-1355	22	29	of	of	ADP
ajlm-1355	22	30	paediatric	paediatric	ADJ
ajlm-1355	22	31	cases.1,2	cases.1,2	PROPN
ajlm-1355	22	32	rarer	rarer	ADV
ajlm-1355	22	33	still	still	ADV
ajlm-1355	22	34	is	be	AUX
ajlm-1355	22	35	a	a	DET
ajlm-1355	22	36	pure	pure	ADJ
ajlm-1355	22	37	lymphomatous	lymphomatous	ADJ
ajlm-1355	22	38	version	version	NOUN
ajlm-1355	22	39	(	(	PUNCT
ajlm-1355	22	40	extranodal	extranodal	NOUN
ajlm-1355	22	41	or	or	CCONJ
ajlm-1355	22	42	nodal	nodal	NOUN
ajlm-1355	22	43	)	)	PUNCT
ajlm-1355	22	44	,	,	PUNCT
ajlm-1355	22	45	which	which	PRON
ajlm-1355	22	46	,	,	PUNCT
ajlm-1355	22	47	to	to	ADP
ajlm-1355	22	48	the	the	DET
ajlm-1355	22	49	best	good	ADJ
ajlm-1355	22	50	of	of	ADP
ajlm-1355	22	51	our	our	PRON
ajlm-1355	22	52	knowledge	knowledge	NOUN
ajlm-1355	22	53	,	,	PUNCT
ajlm-1355	22	54	has	have	AUX
ajlm-1355	22	55	only	only	ADV
ajlm-1355	22	56	been	be	AUX
ajlm-1355	22	57	reported	report	VERB
ajlm-1355	22	58	twice	twice	ADV
ajlm-1355	22	59	in	in	ADP
ajlm-1355	22	60	the	the	DET
ajlm-1355	22	61	literature	literature	NOUN
ajlm-1355	22	62	,	,	PUNCT
ajlm-1355	22	63	one	one	NUM
ajlm-1355	22	64	of	of	ADP
ajlm-1355	22	65	which	which	PRON
ajlm-1355	22	66	was	be	AUX
ajlm-1355	22	67	in	in	ADP
ajlm-1355	22	68	a	a	DET
ajlm-1355	22	69	paediatric	paediatric	NOUN
ajlm-1355	22	70	patient.3,4	patient.3,4	ADP
ajlm-1355	22	71	this	this	DET
ajlm-1355	22	72	entity	entity	NOUN
ajlm-1355	22	73	has	have	AUX
ajlm-1355	22	74	overlapping	overlap	VERB
ajlm-1355	22	75	clinical	clinical	ADJ
ajlm-1355	22	76	and	and	CCONJ
ajlm-1355	22	77	pathological	pathological	ADJ
ajlm-1355	22	78	features	feature	NOUN
ajlm-1355	22	79	with	with	ADP
ajlm-1355	22	80	burkitt	burkitt	PROPN
ajlm-1355	22	81	leukaemia	leukaemia	NOUN
ajlm-1355	22	82	or	or	CCONJ
ajlm-1355	22	83	lymphoma	lymphoma	NOUN
ajlm-1355	22	84	(	(	PUNCT
ajlm-1355	22	85	bll	bll	PROPN
ajlm-1355	22	86	)	)	PUNCT
ajlm-1355	22	87	and	and	CCONJ
ajlm-1355	22	88	precursor	precursor	NOUN
ajlm-1355	22	89	b	b	NOUN
ajlm-1355	22	90	-	-	PUNCT
ajlm-1355	22	91	lymphoblastic	lymphoblastic	ADJ
ajlm-1355	22	92	leukaemia	leukaemia	NOUN
ajlm-1355	22	93	or	or	CCONJ
ajlm-1355	22	94	lymphoma	lymphoma	NOUN
ajlm-1355	22	95	(	(	PUNCT
ajlm-1355	22	96	b	b	X
ajlm-1355	22	97	-	-	PUNCT
ajlm-1355	22	98	all	all	PRON
ajlm-1355	22	99	)	)	PUNCT
ajlm-1355	22	100	.	.	PUNCT
ajlm-1355	23	1	it	it	PRON
ajlm-1355	23	2	has	have	AUX
ajlm-1355	23	3	been	be	AUX
ajlm-1355	23	4	described	describe	VERB
ajlm-1355	23	5	across	across	ADP
ajlm-1355	23	6	a	a	DET
ajlm-1355	23	7	spectrum	spectrum	NOUN
ajlm-1355	23	8	of	of	ADP
ajlm-1355	23	9	ages	age	NOUN
ajlm-1355	23	10	ranging	range	VERB
ajlm-1355	23	11	from	from	ADP
ajlm-1355	23	12	32	32	NUM
ajlm-1355	23	13	months	month	NOUN
ajlm-1355	23	14	to	to	ADP
ajlm-1355	23	15	64	64	NUM
ajlm-1355	23	16	years	year	NOUN
ajlm-1355	23	17	,	,	PUNCT
ajlm-1355	23	18	in	in	ADP
ajlm-1355	23	19	both	both	CCONJ
ajlm-1355	23	20	male	male	ADJ
ajlm-1355	23	21	and	and	CCONJ
ajlm-1355	23	22	female	female	ADJ
ajlm-1355	23	23	patients	patient	NOUN
ajlm-1355	23	24	.	.	PUNCT
ajlm-1355	24	1	peripheral	peripheral	ADJ
ajlm-1355	24	2	blood	blood	NOUN
ajlm-1355	24	3	and	and	CCONJ
ajlm-1355	24	4	bone	bone	NOUN
ajlm-1355	24	5	marrow	marrow	PROPN
ajlm-1355	24	6	involvement	involvement	NOUN
ajlm-1355	24	7	have	have	AUX
ajlm-1355	24	8	been	be	AUX
ajlm-1355	24	9	reported	report	VERB
ajlm-1355	24	10	in	in	ADP
ajlm-1355	24	11	the	the	DET
ajlm-1355	24	12	majority	majority	NOUN
ajlm-1355	24	13	of	of	ADP
ajlm-1355	24	14	cases	case	NOUN
ajlm-1355	24	15	,	,	PUNCT
ajlm-1355	24	16	with	with	ADP
ajlm-1355	24	17	isolated	isolated	ADJ
ajlm-1355	24	18	extranodal	extranodal	NOUN
ajlm-1355	24	19	disease	disease	NOUN
ajlm-1355	24	20	reported	report	VERB
ajlm-1355	24	21	in	in	ADP
ajlm-1355	24	22	only	only	ADV
ajlm-1355	24	23	a	a	DET
ajlm-1355	24	24	few.1,3,4,5	few.1,3,4,5	NOUN
ajlm-1355	24	25	the	the	DET
ajlm-1355	24	26	immunophenotype	immunophenotype	NOUN
ajlm-1355	24	27	is	be	AUX
ajlm-1355	24	28	that	that	PRON
ajlm-1355	24	29	of	of	ADP
ajlm-1355	24	30	a	a	DET
ajlm-1355	24	31	precursor	precursor	NOUN
ajlm-1355	24	32	b	b	NOUN
ajlm-1355	24	33	-	-	PUNCT
ajlm-1355	24	34	cell	cell	NOUN
ajlm-1355	24	35	,	,	PUNCT
ajlm-1355	24	36	with	with	ADP
ajlm-1355	24	37	the	the	DET
ajlm-1355	24	38	expression	expression	NOUN
ajlm-1355	24	39	of	of	ADP
ajlm-1355	24	40	cd19	cd19	PROPN
ajlm-1355	24	41	,	,	PUNCT
ajlm-1355	24	42	cd10	cd10	PROPN
ajlm-1355	24	43	and	and	CCONJ
ajlm-1355	24	44	terminal	terminal	ADJ
ajlm-1355	24	45	deoxynucleotidyl	deoxynucleotidyl	NOUN
ajlm-1355	24	46	transferase	transferase	NOUN
ajlm-1355	24	47	(	(	PUNCT
ajlm-1355	24	48	tdt	tdt	PROPN
ajlm-1355	24	49	)	)	PUNCT
ajlm-1355	24	50	,	,	PUNCT
ajlm-1355	24	51	varied	varied	ADJ
ajlm-1355	24	52	expression	expression	NOUN
ajlm-1355	24	53	of	of	ADP
ajlm-1355	24	54	cd34	cd34	PROPN
ajlm-1355	24	55	,	,	PUNCT
ajlm-1355	24	56	and	and	CCONJ
ajlm-1355	24	57	no	no	DET
ajlm-1355	24	58	expression	expression	NOUN
ajlm-1355	24	59	of	of	ADP
ajlm-1355	24	60	both	both	DET
ajlm-1355	24	61	surface	surface	NOUN
ajlm-1355	24	62	light	light	NOUN
ajlm-1355	24	63	chain	chain	NOUN
ajlm-1355	24	64	and	and	CCONJ
ajlm-1355	24	65	cd20	cd20	PROPN
ajlm-1355	24	66	.	.	PUNCT
ajlm-1355	25	1	molecular	molecular	ADJ
ajlm-1355	25	2	studies	study	NOUN
ajlm-1355	25	3	have	have	AUX
ajlm-1355	25	4	confirmed	confirm	VERB
ajlm-1355	25	5	the	the	DET
ajlm-1355	25	6	involvement	involvement	NOUN
ajlm-1355	25	7	of	of	ADP
ajlm-1355	25	8	the	the	DET
ajlm-1355	25	9	myc	myc	PROPN
ajlm-1355	25	10	gene	gene	NOUN
ajlm-1355	25	11	in	in	ADP
ajlm-1355	25	12	a	a	DET
ajlm-1355	25	13	translocation	translocation	NOUN
ajlm-1355	25	14	t(8;14	t(8;14	NOUN
ajlm-1355	25	15	)	)	PUNCT
ajlm-1355	25	16	or	or	CCONJ
ajlm-1355	25	17	variant	variant	ADJ
ajlm-1355	25	18	translocation	translocation	NOUN
ajlm-1355	25	19	,	,	PUNCT
ajlm-1355	25	20	which	which	PRON
ajlm-1355	25	21	is	be	AUX
ajlm-1355	25	22	the	the	DET
ajlm-1355	25	23	molecular	molecular	ADJ
ajlm-1355	25	24	hallmark	hallmark	NOUN
ajlm-1355	25	25	of	of	ADP
ajlm-1355	25	26	bll.2	bll.2	PROPN
ajlm-1355	25	27	this	this	DET
ajlm-1355	25	28	genetic	genetic	ADJ
ajlm-1355	25	29	aberration	aberration	NOUN
ajlm-1355	25	30	has	have	AUX
ajlm-1355	25	31	largely	largely	ADV
ajlm-1355	25	32	directed	direct	VERB
ajlm-1355	25	33	the	the	DET
ajlm-1355	25	34	choice	choice	NOUN
ajlm-1355	25	35	of	of	ADP
ajlm-1355	25	36	therapy	therapy	NOUN
ajlm-1355	25	37	towards	towards	ADP
ajlm-1355	25	38	a	a	DET
ajlm-1355	25	39	mature	mature	ADJ
ajlm-1355	25	40	b	b	NOUN
ajlm-1355	25	41	-	-	PUNCT
ajlm-1355	25	42	cell	cell	NOUN
ajlm-1355	25	43	or	or	CCONJ
ajlm-1355	25	44	burkitt	burkitt	NOUN
ajlm-1355	25	45	-	-	PUNCT
ajlm-1355	25	46	like	like	ADJ
ajlm-1355	25	47	protocol	protocol	NOUN
ajlm-1355	25	48	in	in	ADP
ajlm-1355	25	49	almost	almost	ADV
ajlm-1355	25	50	all	all	PRON
ajlm-1355	25	51	reported	report	VERB
ajlm-1355	25	52	cases	case	NOUN
ajlm-1355	25	53	.	.	PUNCT
ajlm-1355	26	1	it	it	PRON
ajlm-1355	26	2	is	be	AUX
ajlm-1355	26	3	uncertain	uncertain	ADJ
ajlm-1355	26	4	whether	whether	SCONJ
ajlm-1355	26	5	this	this	PRON
ajlm-1355	26	6	represents	represent	VERB
ajlm-1355	26	7	the	the	DET
ajlm-1355	26	8	best	good	ADJ
ajlm-1355	26	9	therapeutic	therapeutic	ADJ
ajlm-1355	26	10	approach	approach	NOUN
ajlm-1355	26	11	as	as	SCONJ
ajlm-1355	26	12	there	there	PRON
ajlm-1355	26	13	is	be	VERB
ajlm-1355	26	14	very	very	ADV
ajlm-1355	26	15	limited	limited	ADJ
ajlm-1355	26	16	data	datum	NOUN
ajlm-1355	26	17	on	on	ADP
ajlm-1355	26	18	both	both	CCONJ
ajlm-1355	26	19	the	the	DET
ajlm-1355	26	20	duration	duration	NOUN
ajlm-1355	26	21	of	of	ADP
ajlm-1355	26	22	remission	remission	NOUN
ajlm-1355	26	23	in	in	ADP
ajlm-1355	26	24	these	these	DET
ajlm-1355	26	25	patients	patient	NOUN
ajlm-1355	26	26	and	and	CCONJ
ajlm-1355	26	27	the	the	DET
ajlm-1355	26	28	exact	exact	ADJ
ajlm-1355	26	29	underlying	underlying	ADJ
ajlm-1355	26	30	molecular	molecular	ADJ
ajlm-1355	26	31	behaviour	behaviour	NOUN
ajlm-1355	26	32	of	of	ADP
ajlm-1355	26	33	this	this	DET
ajlm-1355	26	34	tumour	tumour	NOUN
ajlm-1355	26	35	.	.	PUNCT
ajlm-1355	27	1	this	this	DET
ajlm-1355	27	2	case	case	NOUN
ajlm-1355	27	3	study	study	NOUN
ajlm-1355	27	4	highlights	highlight	VERB
ajlm-1355	27	5	this	this	DET
ajlm-1355	27	6	rare	rare	ADJ
ajlm-1355	27	7	entity	entity	NOUN
ajlm-1355	27	8	,	,	PUNCT
ajlm-1355	27	9	as	as	ADV
ajlm-1355	27	10	well	well	ADV
ajlm-1355	27	11	as	as	ADP
ajlm-1355	27	12	its	its	PRON
ajlm-1355	27	13	associated	associated	ADJ
ajlm-1355	27	14	diagnostic	diagnostic	ADJ
ajlm-1355	27	15	and	and	CCONJ
ajlm-1355	27	16	therapeutic	therapeutic	ADJ
ajlm-1355	27	17	challenges	challenge	NOUN
ajlm-1355	27	18	.	.	PUNCT
ajlm-1355	28	1	ethical	ethical	ADJ
ajlm-1355	28	2	considerations	consideration	NOUN
ajlm-1355	28	3	parental	parental	ADJ
ajlm-1355	28	4	informed	informed	ADJ
ajlm-1355	28	5	consent	consent	NOUN
ajlm-1355	28	6	was	be	AUX
ajlm-1355	28	7	provided	provide	VERB
ajlm-1355	28	8	for	for	ADP
ajlm-1355	28	9	this	this	DET
ajlm-1355	28	10	case	case	NOUN
ajlm-1355	28	11	report	report	NOUN
ajlm-1355	28	12	.	.	PUNCT
ajlm-1355	29	1	the	the	DET
ajlm-1355	29	2	ethical	ethical	ADJ
ajlm-1355	29	3	clearance	clearance	NOUN
ajlm-1355	29	4	was	be	AUX
ajlm-1355	29	5	obtained	obtain	VERB
ajlm-1355	29	6	from	from	ADP
ajlm-1355	29	7	the	the	DET
ajlm-1355	29	8	university	university	NOUN
ajlm-1355	29	9	of	of	ADP
ajlm-1355	29	10	the	the	DET
ajlm-1355	29	11	witwatersrand	witwatersrand	NOUN
ajlm-1355	29	12	human	human	PROPN
ajlm-1355	29	13	research	research	PROPN
ajlm-1355	29	14	ethics	ethic	NOUN
ajlm-1355	29	15	committee	committee	PROPN
ajlm-1355	29	16	(	(	PUNCT
ajlm-1355	29	17	medical	medical	ADJ
ajlm-1355	29	18	)	)	PUNCT
ajlm-1355	29	19	,	,	PUNCT
ajlm-1355	29	20	johannesburg	johannesburg	PROPN
ajlm-1355	29	21	,	,	PUNCT
ajlm-1355	29	22	south	south	PROPN
ajlm-1355	29	23	africa	africa	PROPN
ajlm-1355	29	24	,	,	PUNCT
ajlm-1355	29	25	under	under	ADP
ajlm-1355	29	26	the	the	DET
ajlm-1355	29	27	approval	approval	NOUN
ajlm-1355	29	28	number	number	NOUN
ajlm-1355	29	29	m190356	m190356	NOUN
ajlm-1355	29	30	.	.	PUNCT
ajlm-1355	30	1	patient	patient	ADJ
ajlm-1355	30	2	results	result	NOUN
ajlm-1355	30	3	were	be	AUX
ajlm-1355	30	4	de	de	ADJ
ajlm-1355	30	5	-	-	VERB
ajlm-1355	30	6	identified	identify	VERB
ajlm-1355	30	7	and	and	CCONJ
ajlm-1355	30	8	stored	store	VERB
ajlm-1355	30	9	in	in	ADP
ajlm-1355	30	10	a	a	DET
ajlm-1355	30	11	secure	secure	ADJ
ajlm-1355	30	12	database	database	NOUN
ajlm-1355	30	13	to	to	PART
ajlm-1355	30	14	ensure	ensure	VERB
ajlm-1355	30	15	patient	patient	ADJ
ajlm-1355	30	16	confidentiality	confidentiality	NOUN
ajlm-1355	30	17	.	.	PUNCT
ajlm-1355	31	1	case	case	NOUN
ajlm-1355	31	2	presentation	presentation	NOUN
ajlm-1355	31	3	a	a	DET
ajlm-1355	31	4	9	9	NUM
ajlm-1355	31	5	-	-	PUNCT
ajlm-1355	31	6	month	month	NOUN
ajlm-1355	31	7	-	-	PUNCT
ajlm-1355	31	8	old	old	ADJ
ajlm-1355	31	9	male	male	ADJ
ajlm-1355	31	10	patient	patient	NOUN
ajlm-1355	31	11	from	from	ADP
ajlm-1355	31	12	angola	angola	PROPN
ajlm-1355	31	13	presented	present	VERB
ajlm-1355	31	14	to	to	ADP
ajlm-1355	31	15	the	the	DET
ajlm-1355	31	16	charlotte	charlotte	PROPN
ajlm-1355	31	17	maxeke	maxeke	PROPN
ajlm-1355	31	18	johannesburg	johannesburg	PROPN
ajlm-1355	31	19	academic	academic	ADJ
ajlm-1355	31	20	hospital	hospital	PROPN
ajlm-1355	31	21	,	,	PUNCT
ajlm-1355	31	22	south	south	PROPN
ajlm-1355	31	23	africa	africa	PROPN
ajlm-1355	31	24	,	,	PUNCT
ajlm-1355	31	25	in	in	ADP
ajlm-1355	31	26	february	february	PROPN
ajlm-1355	31	27	2019	2019	NUM
ajlm-1355	31	28	,	,	PUNCT
ajlm-1355	31	29	with	with	ADP
ajlm-1355	31	30	a	a	DET
ajlm-1355	31	31	3–4	3–4	NUM
ajlm-1355	31	32	-	-	PUNCT
ajlm-1355	31	33	week	week	NOUN
ajlm-1355	31	34	history	history	NOUN
ajlm-1355	31	35	of	of	ADP
ajlm-1355	31	36	progressive	progressive	ADJ
ajlm-1355	31	37	bilateral	bilateral	ADJ
ajlm-1355	31	38	proptosis	proptosis	NOUN
ajlm-1355	31	39	and	and	CCONJ
ajlm-1355	31	40	scalp	scalp	NOUN
ajlm-1355	31	41	masses	masse	NOUN
ajlm-1355	31	42	.	.	PUNCT
ajlm-1355	32	1	the	the	DET
ajlm-1355	32	2	computed	compute	VERB
ajlm-1355	32	3	tomography	tomography	NOUN
ajlm-1355	32	4	scan	scan	PROPN
ajlm-1355	32	5	identified	identify	VERB
ajlm-1355	32	6	bilateral	bilateral	ADJ
ajlm-1355	32	7	occipital	occipital	NOUN
ajlm-1355	32	8	and	and	CCONJ
ajlm-1355	32	9	temporal	temporal	ADJ
ajlm-1355	32	10	scalp	scalp	NOUN
ajlm-1355	32	11	masses	masse	NOUN
ajlm-1355	32	12	with	with	ADP
ajlm-1355	32	13	extracranial	extracranial	ADJ
ajlm-1355	32	14	extension	extension	NOUN
ajlm-1355	32	15	into	into	ADP
ajlm-1355	32	16	the	the	DET
ajlm-1355	32	17	orbital	orbital	ADJ
ajlm-1355	32	18	cavities	cavity	NOUN
ajlm-1355	32	19	and	and	CCONJ
ajlm-1355	32	20	sinuses	sinus	NOUN
ajlm-1355	32	21	,	,	PUNCT
ajlm-1355	32	22	and	and	CCONJ
ajlm-1355	32	23	extradural	extradural	ADJ
ajlm-1355	32	24	extension	extension	NOUN
ajlm-1355	32	25	into	into	ADP
ajlm-1355	32	26	the	the	DET
ajlm-1355	32	27	anterior	anterior	ADJ
ajlm-1355	32	28	cranial	cranial	ADJ
ajlm-1355	32	29	fossa	fossa	NOUN
ajlm-1355	32	30	.	.	PUNCT
ajlm-1355	33	1	there	there	PRON
ajlm-1355	33	2	was	be	VERB
ajlm-1355	33	3	no	no	DET
ajlm-1355	33	4	hepatosplenomegaly	hepatosplenomegaly	NOUN
ajlm-1355	33	5	or	or	CCONJ
ajlm-1355	33	6	lymphadenopathy	lymphadenopathy	ADJ
ajlm-1355	33	7	.	.	PUNCT
ajlm-1355	34	1	a	a	DET
ajlm-1355	34	2	fine	fine	ADJ
ajlm-1355	34	3	needle	needle	NOUN
ajlm-1355	34	4	aspiration	aspiration	NOUN
ajlm-1355	34	5	sample	sample	NOUN
ajlm-1355	34	6	of	of	ADP
ajlm-1355	34	7	the	the	DET
ajlm-1355	34	8	soft	soft	ADJ
ajlm-1355	34	9	tissue	tissue	NOUN
ajlm-1355	34	10	scalp	scalp	NOUN
ajlm-1355	34	11	mass	mass	NOUN
ajlm-1355	34	12	was	be	AUX
ajlm-1355	34	13	submitted	submit	VERB
ajlm-1355	34	14	for	for	ADP
ajlm-1355	34	15	flow	flow	NOUN
ajlm-1355	34	16	cytometry	cytometry	NOUN
ajlm-1355	34	17	,	,	PUNCT
ajlm-1355	34	18	and	and	CCONJ
ajlm-1355	34	19	a	a	DET
ajlm-1355	34	20	tru	tru	NOUN
ajlm-1355	34	21	-	-	PUNCT
ajlm-1355	34	22	cut	cut	VERB
ajlm-1355	34	23	biopsy	biopsy	NOUN
ajlm-1355	34	24	(	(	PUNCT
ajlm-1355	34	25	manufacturer	manufacturer	NOUN
ajlm-1355	34	26	unknown	unknown	ADJ
ajlm-1355	34	27	)	)	PUNCT
ajlm-1355	34	28	for	for	ADP
ajlm-1355	34	29	histological	histological	ADJ
ajlm-1355	34	30	assessment	assessment	NOUN
ajlm-1355	34	31	at	at	ADP
ajlm-1355	34	32	the	the	DET
ajlm-1355	34	33	national	national	PROPN
ajlm-1355	34	34	health	health	PROPN
ajlm-1355	34	35	laboratory	laboratory	PROPN
ajlm-1355	34	36	service	service	NOUN
ajlm-1355	34	37	.	.	PUNCT
ajlm-1355	35	1	as	as	SCONJ
ajlm-1355	35	2	part	part	NOUN
ajlm-1355	35	3	of	of	ADP
ajlm-1355	35	4	the	the	DET
ajlm-1355	35	5	staging	staging	NOUN
ajlm-1355	35	6	work	work	NOUN
ajlm-1355	35	7	up	up	ADP
ajlm-1355	35	8	,	,	PUNCT
ajlm-1355	35	9	bone	bone	NOUN
ajlm-1355	35	10	marrow	marrow	NOUN
ajlm-1355	35	11	aspiration	aspiration	NOUN
ajlm-1355	35	12	and	and	CCONJ
ajlm-1355	35	13	a	a	DET
ajlm-1355	35	14	trephine	trephine	ADJ
ajlm-1355	35	15	biopsy	biopsy	NOUN
ajlm-1355	35	16	were	be	AUX
ajlm-1355	35	17	performed	perform	VERB
ajlm-1355	35	18	to	to	PART
ajlm-1355	35	19	exclude	exclude	VERB
ajlm-1355	35	20	infiltration	infiltration	NOUN
ajlm-1355	35	21	of	of	ADP
ajlm-1355	35	22	the	the	DET
ajlm-1355	35	23	marrow	marrow	NOUN
ajlm-1355	35	24	.	.	PUNCT
ajlm-1355	36	1	laboratory	laboratory	NOUN
ajlm-1355	36	2	methods	method	NOUN
ajlm-1355	36	3	flow	flow	VERB
ajlm-1355	36	4	cytometry	cytometry	NOUN
ajlm-1355	36	5	was	be	AUX
ajlm-1355	36	6	performed	perform	VERB
ajlm-1355	36	7	on	on	ADP
ajlm-1355	36	8	the	the	DET
ajlm-1355	36	9	fine	fine	ADJ
ajlm-1355	36	10	needle	needle	NOUN
ajlm-1355	36	11	aspiration	aspiration	NOUN
ajlm-1355	36	12	sample	sample	NOUN
ajlm-1355	36	13	from	from	ADP
ajlm-1355	36	14	the	the	DET
ajlm-1355	36	15	scalp	scalp	NOUN
ajlm-1355	36	16	mass	mass	NOUN
ajlm-1355	36	17	on	on	ADP
ajlm-1355	36	18	a	a	DET
ajlm-1355	36	19	facs	facs	PROPN
ajlm-1355	36	20	calibur	calibur	PROPN
ajlm-1355	36	21	instrument	instrument	PROPN
ajlm-1355	36	22	(	(	PUNCT
ajlm-1355	36	23	bd	bd	PROPN
ajlm-1355	36	24	biosciences	bioscience	NOUN
ajlm-1355	36	25	,	,	PUNCT
ajlm-1355	36	26	san	san	PROPN
ajlm-1355	36	27	jose	jose	PROPN
ajlm-1355	36	28	,	,	PUNCT
ajlm-1355	36	29	california	california	PROPN
ajlm-1355	36	30	,	,	PUNCT
ajlm-1355	36	31	united	united	PROPN
ajlm-1355	36	32	states	states	PROPN
ajlm-1355	36	33	)	)	PUNCT
ajlm-1355	36	34	,	,	PUNCT
ajlm-1355	36	35	using	use	VERB
ajlm-1355	36	36	the	the	DET
ajlm-1355	36	37	paint	paint	NOUN
ajlm-1355	36	38	-	-	PUNCT
ajlm-1355	36	39	a	a	DET
ajlm-1355	36	40	-	-	PUNCT
ajlm-1355	36	41	gate	gate	NOUN
ajlm-1355	36	42	(	(	PUNCT
ajlm-1355	36	43	becton	becton	PROPN
ajlm-1355	36	44	dickinson	dickinson	PROPN
ajlm-1355	36	45	,	,	PUNCT
ajlm-1355	36	46	bd	bd	PROPN
ajlm-1355	36	47	biosciences	bioscience	NOUN
ajlm-1355	36	48	,	,	PUNCT
ajlm-1355	36	49	san	san	PROPN
ajlm-1355	36	50	jose	jose	PROPN
ajlm-1355	36	51	,	,	PUNCT
ajlm-1355	36	52	california	california	PROPN
ajlm-1355	36	53	,	,	PUNCT
ajlm-1355	36	54	united	united	PROPN
ajlm-1355	36	55	states	states	PROPN
ajlm-1355	36	56	)	)	PUNCT
ajlm-1355	36	57	and	and	CCONJ
ajlm-1355	36	58	modfit	modfit	NOUN
ajlm-1355	36	59	(	(	PUNCT
ajlm-1355	36	60	verity	verity	NOUN
ajlm-1355	36	61	software	software	NOUN
ajlm-1355	36	62	house	house	PROPN
ajlm-1355	36	63	,	,	PUNCT
ajlm-1355	36	64	topsham	topsham	PROPN
ajlm-1355	36	65	,	,	PUNCT
ajlm-1355	36	66	maine	maine	PROPN
ajlm-1355	36	67	,	,	PUNCT
ajlm-1355	36	68	united	united	PROPN
ajlm-1355	36	69	states	states	PROPN
ajlm-1355	36	70	)	)	PUNCT
ajlm-1355	36	71	software	software	NOUN
ajlm-1355	36	72	.	.	PUNCT
ajlm-1355	37	1	the	the	DET
ajlm-1355	37	2	following	follow	VERB
ajlm-1355	37	3	antibodies	antibody	NOUN
ajlm-1355	37	4	were	be	AUX
ajlm-1355	37	5	used	use	VERB
ajlm-1355	37	6	:	:	PUNCT
ajlm-1355	37	7	cd19	cd19	PROPN
ajlm-1355	37	8	fitc	fitc	PROPN
ajlm-1355	37	9	(	(	PUNCT
ajlm-1355	37	10	becton	becton	PROPN
ajlm-1355	37	11	dickinson	dickinson	PROPN
ajlm-1355	37	12	,	,	PUNCT
ajlm-1355	37	13	bd	bd	PROPN
ajlm-1355	37	14	biosciences	bioscience	NOUN
ajlm-1355	37	15	,	,	PUNCT
ajlm-1355	37	16	san	san	PROPN
ajlm-1355	37	17	jose	jose	PROPN
ajlm-1355	37	18	,	,	PUNCT
ajlm-1355	37	19	california	california	PROPN
ajlm-1355	37	20	,	,	PUNCT
ajlm-1355	37	21	united	united	PROPN
ajlm-1355	37	22	states	states	PROPN
ajlm-1355	37	23	)	)	PUNCT
ajlm-1355	37	24	,	,	PUNCT
ajlm-1355	37	25	cd10	cd10	PROPN
ajlm-1355	37	26	pe	pe	PROPN
ajlm-1355	37	27	(	(	PUNCT
ajlm-1355	37	28	beckman	beckman	PROPN
ajlm-1355	37	29	coulter	coulter	PROPN
ajlm-1355	37	30	inc	inc	PROPN
ajlm-1355	37	31	.	.	PROPN
ajlm-1355	37	32	,	,	PUNCT
ajlm-1355	37	33	brea	brea	PROPN
ajlm-1355	37	34	,	,	PUNCT
ajlm-1355	37	35	california	california	PROPN
ajlm-1355	37	36	,	,	PUNCT
ajlm-1355	37	37	united	united	PROPN
ajlm-1355	37	38	states	states	PROPN
ajlm-1355	37	39	)	)	PUNCT
ajlm-1355	37	40	,	,	PUNCT
ajlm-1355	37	41	cd45	cd45	PROPN
ajlm-1355	37	42	percp	percp	PROPN
ajlm-1355	37	43	(	(	PUNCT
ajlm-1355	37	44	becton	becton	PROPN
ajlm-1355	37	45	dickinson	dickinson	PROPN
ajlm-1355	37	46	,	,	PUNCT
ajlm-1355	37	47	bd	bd	PROPN
ajlm-1355	37	48	biosciences	bioscience	NOUN
ajlm-1355	37	49	,	,	PUNCT
ajlm-1355	37	50	san	san	PROPN
ajlm-1355	37	51	jose	jose	PROPN
ajlm-1355	37	52	,	,	PUNCT
ajlm-1355	37	53	california	california	PROPN
ajlm-1355	37	54	,	,	PUNCT
ajlm-1355	37	55	united	united	PROPN
ajlm-1355	37	56	states	states	PROPN
ajlm-1355	37	57	)	)	PUNCT
ajlm-1355	37	58	,	,	PUNCT
ajlm-1355	37	59	cd34	cd34	PROPN
ajlm-1355	37	60	apc	apc	PROPN
ajlm-1355	37	61	(	(	PUNCT
ajlm-1355	37	62	becton	becton	PROPN
ajlm-1355	37	63	dickinson	dickinson	PROPN
ajlm-1355	37	64	,	,	PUNCT
ajlm-1355	37	65	bd	bd	PROPN
ajlm-1355	37	66	biosciences	bioscience	NOUN
ajlm-1355	37	67	,	,	PUNCT
ajlm-1355	37	68	san	san	PROPN
ajlm-1355	37	69	jose	jose	PROPN
ajlm-1355	37	70	,	,	PUNCT
ajlm-1355	37	71	california	california	PROPN
ajlm-1355	37	72	,	,	PUNCT
ajlm-1355	37	73	united	united	PROPN
ajlm-1355	37	74	states	states	PROPN
ajlm-1355	37	75	)	)	PUNCT
ajlm-1355	37	76	,	,	PUNCT
ajlm-1355	37	77	cd117	cd117	PROPN
ajlm-1355	37	78	pe	pe	PROPN
ajlm-1355	37	79	(	(	PUNCT
ajlm-1355	37	80	beckman	beckman	PROPN
ajlm-1355	37	81	coulter	coulter	PROPN
ajlm-1355	37	82	inc	inc	PROPN
ajlm-1355	37	83	.	.	PROPN
ajlm-1355	37	84	,	,	PUNCT
ajlm-1355	37	85	brea	brea	PROPN
ajlm-1355	37	86	,	,	PUNCT
ajlm-1355	37	87	california	california	PROPN
ajlm-1355	37	88	,	,	PUNCT
ajlm-1355	37	89	united	united	PROPN
ajlm-1355	37	90	states	states	PROPN
ajlm-1355	37	91	)	)	PUNCT
ajlm-1355	37	92	,	,	PUNCT
ajlm-1355	37	93	hla	hla	PROPN
ajlm-1355	37	94	-	-	PUNCT
ajlm-1355	37	95	dr	dr	PROPN
ajlm-1355	37	96	fitc	fitc	PROPN
ajlm-1355	37	97	(	(	PUNCT
ajlm-1355	37	98	becton	becton	PROPN
ajlm-1355	37	99	dickinson	dickinson	PROPN
ajlm-1355	37	100	,	,	PUNCT
ajlm-1355	37	101	bd	bd	PROPN
ajlm-1355	37	102	biosciences	bioscience	NOUN
ajlm-1355	37	103	,	,	PUNCT
ajlm-1355	37	104	san	san	PROPN
ajlm-1355	37	105	jose	jose	PROPN
ajlm-1355	37	106	,	,	PUNCT
ajlm-1355	37	107	california	california	PROPN
ajlm-1355	37	108	,	,	PUNCT
ajlm-1355	37	109	united	united	PROPN
ajlm-1355	37	110	states	states	PROPN
ajlm-1355	37	111	)	)	PUNCT
ajlm-1355	37	112	,	,	PUNCT
ajlm-1355	37	113	cd13	cd13	PROPN
ajlm-1355	37	114	pe	pe	PROPN
ajlm-1355	37	115	(	(	PUNCT
ajlm-1355	37	116	beckman	beckman	PROPN
ajlm-1355	37	117	coulter	coulter	PROPN
ajlm-1355	37	118	inc	inc	PROPN
ajlm-1355	37	119	.	.	PROPN
ajlm-1355	37	120	,	,	PUNCT
ajlm-1355	37	121	brea	brea	PROPN
ajlm-1355	37	122	,	,	PUNCT
ajlm-1355	37	123	california	california	PROPN
ajlm-1355	37	124	,	,	PUNCT
ajlm-1355	37	125	united	united	PROPN
ajlm-1355	37	126	states	states	PROPN
ajlm-1355	37	127	)	)	PUNCT
ajlm-1355	37	128	,	,	PUNCT
ajlm-1355	37	129	kappa	kappa	PROPN
ajlm-1355	37	130	fitc	fitc	PROPN
ajlm-1355	37	131	(	(	PUNCT
ajlm-1355	37	132	dako	dako	PROPN
ajlm-1355	37	133	,	,	PUNCT
ajlm-1355	37	134	glostrup	glostrup	NOUN
ajlm-1355	37	135	,	,	PUNCT
ajlm-1355	37	136	denmark	denmark	NOUN
ajlm-1355	37	137	)	)	PUNCT
ajlm-1355	37	138	,	,	PUNCT
ajlm-1355	37	139	lambda	lambda	NOUN
ajlm-1355	37	140	pe	pe	PROPN
ajlm-1355	37	141	(	(	PUNCT
ajlm-1355	37	142	dako	dako	PROPN
ajlm-1355	37	143	,	,	PUNCT
ajlm-1355	37	144	glostrup	glostrup	NOUN
ajlm-1355	37	145	,	,	PUNCT
ajlm-1355	37	146	denmark	denmark	NOUN
ajlm-1355	37	147	)	)	PUNCT
ajlm-1355	37	148	and	and	CCONJ
ajlm-1355	37	149	cytoplasmic	cytoplasmic	ADJ
ajlm-1355	37	150	tdt	tdt	PROPN
ajlm-1355	37	151	fitc	fitc	PROPN
ajlm-1355	37	152	(	(	PUNCT
ajlm-1355	37	153	dako	dako	PROPN
ajlm-1355	37	154	,	,	PUNCT
ajlm-1355	37	155	glostrup	glostrup	NOUN
ajlm-1355	37	156	,	,	PUNCT
ajlm-1355	37	157	denmark	denmark	PROPN
ajlm-1355	37	158	)	)	PUNCT
ajlm-1355	37	159	.	.	PUNCT
ajlm-1355	38	1	immunohistochemical	immunohistochemical	ADJ
ajlm-1355	38	2	work	work	NOUN
ajlm-1355	38	3	up	up	ADP
ajlm-1355	38	4	was	be	AUX
ajlm-1355	38	5	performed	perform	VERB
ajlm-1355	38	6	on	on	ADP
ajlm-1355	38	7	the	the	DET
ajlm-1355	38	8	tru	tru	PROPN
ajlm-1355	38	9	-	-	PUNCT
ajlm-1355	38	10	cut	cut	VERB
ajlm-1355	38	11	biopsy	biopsy	NOUN
ajlm-1355	38	12	from	from	ADP
ajlm-1355	38	13	the	the	DET
ajlm-1355	38	14	scalp	scalp	NOUN
ajlm-1355	38	15	mass	mass	NOUN
ajlm-1355	38	16	using	use	VERB
ajlm-1355	38	17	the	the	DET
ajlm-1355	38	18	following	follow	VERB
ajlm-1355	38	19	stains	stain	NOUN
ajlm-1355	38	20	:	:	PUNCT
ajlm-1355	39	1	cd20	cd20	PROPN
ajlm-1355	39	2	(	(	PUNCT
ajlm-1355	39	3	dako	dako	PROPN
ajlm-1355	39	4	,	,	PUNCT
ajlm-1355	39	5	glostrup	glostrup	NOUN
ajlm-1355	39	6	,	,	PUNCT
ajlm-1355	39	7	denmark	denmark	NOUN
ajlm-1355	39	8	)	)	PUNCT
ajlm-1355	39	9	,	,	PUNCT
ajlm-1355	39	10	pax5	pax5	PROPN
ajlm-1355	39	11	(	(	PUNCT
ajlm-1355	39	12	dako	dako	PROPN
ajlm-1355	39	13	,	,	PUNCT
ajlm-1355	39	14	glostrup	glostrup	NOUN
ajlm-1355	39	15	,	,	PUNCT
ajlm-1355	39	16	denmark	denmark	NOUN
ajlm-1355	39	17	)	)	PUNCT
ajlm-1355	39	18	,	,	PUNCT
ajlm-1355	39	19	cd10	cd10	PROPN
ajlm-1355	39	20	(	(	PUNCT
ajlm-1355	39	21	leica	leica	PROPN
ajlm-1355	39	22	biosystems	biosystems	PROPN
ajlm-1355	39	23	,	,	PUNCT
ajlm-1355	39	24	newcastle	newcastle	PROPN
ajlm-1355	39	25	upon	upon	SCONJ
ajlm-1355	39	26	tyne	tyne	PROPN
ajlm-1355	39	27	,	,	PUNCT
ajlm-1355	39	28	united	united	ADJ
ajlm-1355	39	29	kingdom	kingdom	PROPN
ajlm-1355	39	30	)	)	PUNCT
ajlm-1355	39	31	,	,	PUNCT
ajlm-1355	39	32	tdt	tdt	PROPN
ajlm-1355	39	33	(	(	PUNCT
ajlm-1355	39	34	cell	cell	NOUN
ajlm-1355	39	35	marque	marque	NOUN
ajlm-1355	39	36	,	,	PUNCT
ajlm-1355	39	37	rocklin	rocklin	PROPN
ajlm-1355	39	38	,	,	PUNCT
ajlm-1355	39	39	california	california	PROPN
ajlm-1355	39	40	,	,	PUNCT
ajlm-1355	39	41	united	united	PROPN
ajlm-1355	39	42	states	states	PROPN
ajlm-1355	39	43	)	)	PUNCT
ajlm-1355	39	44	,	,	PUNCT
ajlm-1355	39	45	cd34	cd34	PROPN
ajlm-1355	39	46	(	(	PUNCT
ajlm-1355	39	47	dako	dako	PROPN
ajlm-1355	39	48	,	,	PUNCT
ajlm-1355	39	49	glostrup	glostrup	NOUN
ajlm-1355	39	50	,	,	PUNCT
ajlm-1355	39	51	denmark	denmark	PROPN
ajlm-1355	39	52	)	)	PUNCT
ajlm-1355	39	53	,	,	PUNCT
ajlm-1355	39	54	eber	eber	PROPN
ajlm-1355	39	55	ish	ish	PROPN
ajlm-1355	39	56	(	(	PUNCT
ajlm-1355	39	57	roche	roche	PROPN
ajlm-1355	39	58	,	,	PUNCT
ajlm-1355	39	59	mannheim	mannheim	PROPN
ajlm-1355	39	60	,	,	PUNCT
ajlm-1355	39	61	germany	germany	PROPN
ajlm-1355	39	62	)	)	PUNCT
ajlm-1355	39	63	,	,	PUNCT
ajlm-1355	39	64	bcl2	bcl2	PROPN
ajlm-1355	39	65	(	(	PUNCT
ajlm-1355	39	66	dako	dako	PROPN
ajlm-1355	39	67	,	,	PUNCT
ajlm-1355	39	68	glostrup	glostrup	NOUN
ajlm-1355	39	69	,	,	PUNCT
ajlm-1355	39	70	denmark	denmark	NOUN
ajlm-1355	39	71	)	)	PUNCT
ajlm-1355	39	72	,	,	PUNCT
ajlm-1355	39	73	and	and	CCONJ
ajlm-1355	39	74	ki67	ki67	PROPN
ajlm-1355	39	75	(	(	PUNCT
ajlm-1355	39	76	dako	dako	PROPN
ajlm-1355	39	77	,	,	PUNCT
ajlm-1355	39	78	glostrup	glostrup	NOUN
ajlm-1355	39	79	,	,	PUNCT
ajlm-1355	39	80	denmark	denmark	PROPN
ajlm-1355	39	81	)	)	PUNCT
ajlm-1355	39	82	.	.	PUNCT
ajlm-1355	40	1	fluorescence	fluorescence	PROPN
ajlm-1355	40	2	in	in	ADP
ajlm-1355	40	3	-	-	PUNCT
ajlm-1355	40	4	situ	situ	NOUN
ajlm-1355	40	5	hybridisation	hybridisation	NOUN
ajlm-1355	40	6	for	for	ADP
ajlm-1355	40	7	the	the	DET
ajlm-1355	40	8	detection	detection	NOUN
ajlm-1355	40	9	of	of	ADP
ajlm-1355	40	10	translocation	translocation	NOUN
ajlm-1355	40	11	t(8;14	t(8;14	PROPN
ajlm-1355	40	12	)	)	PUNCT
ajlm-1355	40	13	was	be	AUX
ajlm-1355	40	14	performed	perform	VERB
ajlm-1355	40	15	using	use	VERB
ajlm-1355	40	16	a	a	DET
ajlm-1355	40	17	vysis	vysis	NOUN
ajlm-1355	40	18	lsi	lsi	NOUN
ajlm-1355	40	19	myc	myc	PROPN
ajlm-1355	40	20	/	/	SYM
ajlm-1355	40	21	igh	igh	PROPN
ajlm-1355	40	22	/	/	SYM
ajlm-1355	40	23	cep8	cep8	PROPN
ajlm-1355	40	24	tri	tri	ADJ
ajlm-1355	40	25	-	-	ADJ
ajlm-1355	40	26	colour	colour	ADJ
ajlm-1355	40	27	dual	dual	ADJ
ajlm-1355	40	28	fusion	fusion	NOUN
ajlm-1355	40	29	probe	probe	NOUN
ajlm-1355	40	30	(	(	PUNCT
ajlm-1355	40	31	abbott	abbott	PROPN
ajlm-1355	40	32	,	,	PUNCT
ajlm-1355	40	33	chicago	chicago	PROPN
ajlm-1355	40	34	,	,	PUNCT
ajlm-1355	40	35	illinois	illinois	PROPN
ajlm-1355	40	36	,	,	PUNCT
ajlm-1355	40	37	united	united	PROPN
ajlm-1355	40	38	states	states	PROPN
ajlm-1355	40	39	)	)	PUNCT
ajlm-1355	40	40	,	,	PUNCT
ajlm-1355	40	41	with	with	ADP
ajlm-1355	40	42	orange	orange	ADJ
ajlm-1355	40	43	,	,	PUNCT
ajlm-1355	40	44	green	green	ADJ
ajlm-1355	40	45	and	and	CCONJ
ajlm-1355	40	46	aqua	aqua	NOUN
ajlm-1355	40	47	signals	signal	NOUN
ajlm-1355	40	48	reflecting	reflect	VERB
ajlm-1355	40	49	the	the	DET
ajlm-1355	40	50	myc	myc	NOUN
ajlm-1355	40	51	,	,	PUNCT
ajlm-1355	40	52	igh	igh	PROPN
ajlm-1355	40	53	and	and	CCONJ
ajlm-1355	40	54	centromere	centromere	ADJ
ajlm-1355	40	55	8	8	NUM
ajlm-1355	40	56	regions	region	NOUN
ajlm-1355	40	57	.	.	PUNCT
ajlm-1355	41	1	laboratory	laboratory	NOUN
ajlm-1355	41	2	results	result	VERB
ajlm-1355	41	3	histological	histological	ADJ
ajlm-1355	41	4	examination	examination	NOUN
ajlm-1355	41	5	of	of	ADP
ajlm-1355	41	6	the	the	DET
ajlm-1355	41	7	tru	tru	PROPN
ajlm-1355	41	8	-	-	PUNCT
ajlm-1355	41	9	cut	cut	VERB
ajlm-1355	41	10	biopsy	biopsy	NOUN
ajlm-1355	41	11	of	of	ADP
ajlm-1355	41	12	the	the	DET
ajlm-1355	41	13	scalp	scalp	NOUN
ajlm-1355	41	14	mass	mass	NOUN
ajlm-1355	41	15	revealed	reveal	VERB
ajlm-1355	41	16	intermediate	intermediate	ADJ
ajlm-1355	41	17	-	-	PUNCT
ajlm-1355	41	18	sized	sized	ADJ
ajlm-1355	41	19	tumour	tumour	ADJ
ajlm-1355	41	20	cells	cell	NOUN
ajlm-1355	41	21	with	with	ADP
ajlm-1355	41	22	irregular	irregular	ADJ
ajlm-1355	41	23	nuclear	nuclear	ADJ
ajlm-1355	41	24	contours	contours	NOUN
ajlm-1355	41	25	,	,	PUNCT
ajlm-1355	41	26	a	a	DET
ajlm-1355	41	27	high	high	ADJ
ajlm-1355	41	28	nuclear	nuclear	ADJ
ajlm-1355	41	29	-	-	PUNCT
ajlm-1355	41	30	cytoplasmic	cytoplasmic	ADJ
ajlm-1355	41	31	ratio	ratio	NOUN
ajlm-1355	41	32	,	,	PUNCT
ajlm-1355	41	33	dispersed	disperse	VERB
ajlm-1355	41	34	nuclear	nuclear	ADJ
ajlm-1355	41	35	chromatin	chromatin	NOUN
ajlm-1355	41	36	,	,	PUNCT
ajlm-1355	41	37	and	and	CCONJ
ajlm-1355	41	38	one	one	NUM
ajlm-1355	41	39	to	to	PART
ajlm-1355	41	40	four	four	NUM
ajlm-1355	41	41	inconspicuous	inconspicuous	ADJ
ajlm-1355	41	42	nucleoli	nucleolus	NOUN
ajlm-1355	41	43	present	present	ADJ
ajlm-1355	41	44	within	within	ADP
ajlm-1355	41	45	a	a	DET
ajlm-1355	41	46	prominent	prominent	ADJ
ajlm-1355	41	47	background	background	NOUN
ajlm-1355	41	48	of	of	ADP
ajlm-1355	41	49	tingible	tingible	ADJ
ajlm-1355	41	50	body	body	NOUN
ajlm-1355	41	51	macrophages	macrophage	NOUN
ajlm-1355	41	52	(	(	PUNCT
ajlm-1355	41	53	figure	figure	NOUN
ajlm-1355	41	54	1	1	NUM
ajlm-1355	41	55	)	)	PUNCT
ajlm-1355	41	56	.	.	PUNCT
ajlm-1355	42	1	the	the	DET
ajlm-1355	42	2	tumour	tumour	NOUN
ajlm-1355	42	3	immunophenotype	immunophenotype	NOUN
ajlm-1355	42	4	based	base	VERB
ajlm-1355	42	5	on	on	ADP
ajlm-1355	42	6	flow	flow	NOUN
ajlm-1355	42	7	cytometry	cytometry	NOUN
ajlm-1355	42	8	and	and	CCONJ
ajlm-1355	42	9	immunohistochemistry	immunohistochemistry	NOUN
ajlm-1355	42	10	was	be	AUX
ajlm-1355	42	11	that	that	PRON
ajlm-1355	42	12	of	of	ADP
ajlm-1355	42	13	a	a	DET
ajlm-1355	42	14	precursor	precursor	NOUN
ajlm-1355	42	15	b	b	NOUN
ajlm-1355	42	16	-	-	PUNCT
ajlm-1355	42	17	cell	cell	NOUN
ajlm-1355	42	18	,	,	PUNCT
ajlm-1355	42	19	with	with	ADP
ajlm-1355	42	20	the	the	DET
ajlm-1355	42	21	expression	expression	NOUN
ajlm-1355	42	22	of	of	ADP
ajlm-1355	42	23	tdt	tdt	PROPN
ajlm-1355	42	24	,	,	PUNCT
ajlm-1355	42	25	absence	absence	NOUN
ajlm-1355	42	26	of	of	ADP
ajlm-1355	42	27	surface	surface	NOUN
ajlm-1355	42	28	light	light	NOUN
ajlm-1355	42	29	chains	chain	NOUN
ajlm-1355	42	30	and	and	CCONJ
ajlm-1355	42	31	a	a	DET
ajlm-1355	42	32	high	high	ADJ
ajlm-1355	42	33	ki67	ki67	PROPN
ajlm-1355	42	34	index	index	NOUN
ajlm-1355	42	35	(	(	PUNCT
ajlm-1355	42	36	table	table	NOUN
ajlm-1355	42	37	1	1	NUM
ajlm-1355	42	38	,	,	PUNCT
ajlm-1355	42	39	table	table	NOUN
ajlm-1355	42	40	2	2	NUM
ajlm-1355	42	41	and	and	CCONJ
ajlm-1355	42	42	figure	figure	NOUN
ajlm-1355	42	43	2	2	NUM
ajlm-1355	42	44	)	)	PUNCT
ajlm-1355	42	45	.	.	PUNCT
ajlm-1355	43	1	contrastingly	contrastingly	ADV
ajlm-1355	43	2	,	,	PUNCT
ajlm-1355	43	3	the	the	DET
ajlm-1355	43	4	high	high	ADJ
ajlm-1355	43	5	s	s	NOUN
ajlm-1355	43	6	-	-	PUNCT
ajlm-1355	43	7	phase	phase	NOUN
ajlm-1355	43	8	fraction	fraction	NOUN
ajlm-1355	43	9	detected	detect	VERB
ajlm-1355	43	10	was	be	AUX
ajlm-1355	43	11	in	in	ADP
ajlm-1355	43	12	a	a	DET
ajlm-1355	43	13	range	range	NOUN
ajlm-1355	43	14	that	that	PRON
ajlm-1355	43	15	is	be	AUX
ajlm-1355	43	16	typically	typically	ADV
ajlm-1355	43	17	seen	see	VERB
ajlm-1355	43	18	in	in	ADP
ajlm-1355	43	19	burkitt	burkitt	PROPN
ajlm-1355	43	20	leukaemia.6	leukaemia.6	PROPN
ajlm-1355	43	21	given	give	VERB
ajlm-1355	43	22	the	the	DET
ajlm-1355	43	23	latter	latter	ADJ
ajlm-1355	43	24	,	,	PUNCT
ajlm-1355	43	25	fluorescence	fluorescence	NOUN
ajlm-1355	43	26	in	in	ADP
ajlm-1355	43	27	-	-	PUNCT
ajlm-1355	43	28	situ	situ	NOUN
ajlm-1355	43	29	hybridisation	hybridisation	NOUN
ajlm-1355	43	30	analysis	analysis	NOUN
ajlm-1355	43	31	was	be	AUX
ajlm-1355	43	32	requested	request	VERB
ajlm-1355	43	33	and	and	CCONJ
ajlm-1355	43	34	found	find	VERB
ajlm-1355	43	35	to	to	PART
ajlm-1355	43	36	be	be	AUX
ajlm-1355	43	37	positive	positive	ADJ
ajlm-1355	43	38	for	for	ADP
ajlm-1355	43	39	the	the	DET
ajlm-1355	43	40	translocation	translocation	NOUN
ajlm-1355	43	41	t(8;14)(q24;q32	t(8;14)(q24;q32	NUM
ajlm-1355	43	42	)	)	PUNCT
ajlm-1355	43	43	(	(	PUNCT
ajlm-1355	43	44	figure	figure	NOUN
ajlm-1355	43	45	3	3	NUM
ajlm-1355	43	46	)	)	PUNCT
ajlm-1355	43	47	.	.	PUNCT
ajlm-1355	44	1	figure	figure	VERB
ajlm-1355	44	2	1	1	NUM
ajlm-1355	44	3	:	:	PUNCT
ajlm-1355	44	4	tru	tru	ADJ
ajlm-1355	44	5	-	-	PUNCT
ajlm-1355	44	6	cut	cut	VERB
ajlm-1355	44	7	biopsy	biopsy	NOUN
ajlm-1355	44	8	of	of	ADP
ajlm-1355	44	9	scalp	scalp	NOUN
ajlm-1355	44	10	mass	mass	NOUN
ajlm-1355	44	11	of	of	ADP
ajlm-1355	44	12	a	a	DET
ajlm-1355	44	13	9	9	NUM
ajlm-1355	44	14	-	-	PUNCT
ajlm-1355	44	15	month	month	NOUN
ajlm-1355	44	16	-	-	PUNCT
ajlm-1355	44	17	old	old	ADJ
ajlm-1355	44	18	male	male	ADJ
ajlm-1355	44	19	patient	patient	NOUN
ajlm-1355	44	20	who	who	PRON
ajlm-1355	44	21	presented	present	VERB
ajlm-1355	44	22	to	to	ADP
ajlm-1355	44	23	the	the	DET
ajlm-1355	44	24	charlotte	charlotte	PROPN
ajlm-1355	44	25	maxeke	maxeke	PROPN
ajlm-1355	44	26	johannesburg	johannesburg	PROPN
ajlm-1355	44	27	academic	academic	ADJ
ajlm-1355	44	28	hospital	hospital	NOUN
ajlm-1355	44	29	in	in	ADP
ajlm-1355	44	30	february	february	PROPN
ajlm-1355	44	31	2019	2019	NUM
ajlm-1355	44	32	.	.	PUNCT
ajlm-1355	45	1	image	image	NOUN
ajlm-1355	45	2	shows	show	VERB
ajlm-1355	45	3	diffuse	diffuse	VERB
ajlm-1355	45	4	infiltration	infiltration	NOUN
ajlm-1355	45	5	by	by	ADP
ajlm-1355	45	6	intermediate	intermediate	ADJ
ajlm-1355	45	7	-	-	PUNCT
ajlm-1355	45	8	sized	sized	ADJ
ajlm-1355	45	9	tumour	tumour	ADJ
ajlm-1355	45	10	cells	cell	NOUN
ajlm-1355	45	11	with	with	ADP
ajlm-1355	45	12	dispersed	disperse	VERB
ajlm-1355	45	13	nuclear	nuclear	ADJ
ajlm-1355	45	14	chromatin	chromatin	NOUN
ajlm-1355	45	15	,	,	PUNCT
ajlm-1355	45	16	irregular	irregular	ADJ
ajlm-1355	45	17	nuclear	nuclear	ADJ
ajlm-1355	45	18	contours	contours	NOUN
ajlm-1355	45	19	and	and	CCONJ
ajlm-1355	45	20	one	one	NUM
ajlm-1355	45	21	to	to	ADP
ajlm-1355	45	22	four	four	NUM
ajlm-1355	45	23	inconspicuous	inconspicuous	ADJ
ajlm-1355	45	24	nucleoli	nucleolus	NOUN
ajlm-1355	45	25	.	.	PUNCT
ajlm-1355	46	1	numerous	numerous	ADJ
ajlm-1355	46	2	tingible	tingible	ADJ
ajlm-1355	46	3	body	body	NOUN
ajlm-1355	46	4	macrophages	macrophage	NOUN
ajlm-1355	46	5	impart	impart	VERB
ajlm-1355	46	6	a	a	DET
ajlm-1355	46	7	starry	starry	ADJ
ajlm-1355	46	8	sky	sky	NOUN
ajlm-1355	46	9	pattern	pattern	NOUN
ajlm-1355	46	10	.	.	PUNCT
ajlm-1355	47	1	7	7	NUM
ajlm-1355	47	2	mitotic	mitotic	ADJ
ajlm-1355	47	3	figures	figure	NOUN
ajlm-1355	47	4	per	per	ADP
ajlm-1355	47	5	40	40	NUM
ajlm-1355	47	6	hpf	hpf	NOUN
ajlm-1355	47	7	.	.	PUNCT
ajlm-1355	47	8	haematoxylin	haematoxylin	PROPN
ajlm-1355	47	9	&	&	CCONJ
ajlm-1355	47	10	eosin	eosin	PROPN
ajlm-1355	47	11	(	(	PUNCT
ajlm-1355	47	12	h&e	h&e	PROPN
ajlm-1355	47	13	)	)	PUNCT
ajlm-1355	47	14	stain	stain	NOUN
ajlm-1355	47	15	at	at	ADP
ajlm-1355	47	16	×40	×40	PROPN
ajlm-1355	47	17	magnification	magnification	NOUN
ajlm-1355	47	18	.	.	PUNCT
ajlm-1355	48	1	figure	figure	NOUN
ajlm-1355	48	2	2	2	NUM
ajlm-1355	48	3	:	:	PUNCT
ajlm-1355	48	4	terminal	terminal	ADJ
ajlm-1355	48	5	deoxynucleotidyl	deoxynucleotidyl	NOUN
ajlm-1355	48	6	transferase	transferase	NOUN
ajlm-1355	48	7	(	(	PUNCT
ajlm-1355	48	8	tdt	tdt	PROPN
ajlm-1355	48	9	)	)	PUNCT
ajlm-1355	48	10	immunohistochemical	immunohistochemical	ADJ
ajlm-1355	48	11	stain	stain	NOUN
ajlm-1355	48	12	of	of	ADP
ajlm-1355	48	13	tru	tru	PROPN
ajlm-1355	48	14	-	-	PUNCT
ajlm-1355	48	15	cut	cut	VERB
ajlm-1355	48	16	biopsy	biopsy	NOUN
ajlm-1355	48	17	of	of	ADP
ajlm-1355	48	18	scalp	scalp	NOUN
ajlm-1355	48	19	mass	mass	NOUN
ajlm-1355	48	20	from	from	ADP
ajlm-1355	48	21	a	a	DET
ajlm-1355	48	22	9	9	NUM
ajlm-1355	48	23	-	-	PUNCT
ajlm-1355	48	24	month	month	NOUN
ajlm-1355	48	25	-	-	PUNCT
ajlm-1355	48	26	old	old	ADJ
ajlm-1355	48	27	male	male	ADJ
ajlm-1355	48	28	patient	patient	NOUN
ajlm-1355	48	29	who	who	PRON
ajlm-1355	48	30	presented	present	VERB
ajlm-1355	48	31	to	to	ADP
ajlm-1355	48	32	the	the	DET
ajlm-1355	48	33	charlotte	charlotte	PROPN
ajlm-1355	48	34	maxeke	maxeke	PROPN
ajlm-1355	48	35	johannesburg	johannesburg	PROPN
ajlm-1355	48	36	academic	academic	ADJ
ajlm-1355	48	37	hospital	hospital	NOUN
ajlm-1355	48	38	in	in	ADP
ajlm-1355	48	39	february	february	PROPN
ajlm-1355	48	40	2019	2019	NUM
ajlm-1355	48	41	.	.	PUNCT
ajlm-1355	49	1	image	image	NOUN
ajlm-1355	49	2	shows	show	VERB
ajlm-1355	49	3	~40	~40	NOUN
ajlm-1355	49	4	%	%	NOUN
ajlm-1355	49	5	positivity	positivity	NOUN
ajlm-1355	49	6	in	in	ADP
ajlm-1355	49	7	the	the	DET
ajlm-1355	49	8	tumour	tumour	NOUN
ajlm-1355	49	9	.	.	PUNCT
ajlm-1355	50	1	×40	×40	PROPN
ajlm-1355	50	2	magnification	magnification	NOUN
ajlm-1355	50	3	.	.	PUNCT
ajlm-1355	51	1	figure	figure	NOUN
ajlm-1355	51	2	3	3	NUM
ajlm-1355	51	3	:	:	PUNCT
ajlm-1355	51	4	fluorescence	fluorescence	NOUN
ajlm-1355	51	5	in	in	ADP
ajlm-1355	51	6	-	-	PUNCT
ajlm-1355	51	7	situ	situ	ADJ
ajlm-1355	51	8	hybridisation	hybridisation	NOUN
ajlm-1355	51	9	analysis	analysis	NOUN
ajlm-1355	51	10	of	of	ADP
ajlm-1355	51	11	fine	fine	ADJ
ajlm-1355	51	12	needle	needle	NOUN
ajlm-1355	51	13	aspirate	aspirate	NOUN
ajlm-1355	51	14	from	from	ADP
ajlm-1355	51	15	a	a	DET
ajlm-1355	51	16	9	9	NUM
ajlm-1355	51	17	-	-	PUNCT
ajlm-1355	51	18	month	month	NOUN
ajlm-1355	51	19	-	-	PUNCT
ajlm-1355	51	20	old	old	ADJ
ajlm-1355	51	21	male	male	ADJ
ajlm-1355	51	22	patient	patient	NOUN
ajlm-1355	51	23	who	who	PRON
ajlm-1355	51	24	presented	present	VERB
ajlm-1355	51	25	to	to	ADP
ajlm-1355	51	26	the	the	DET
ajlm-1355	51	27	charlotte	charlotte	PROPN
ajlm-1355	51	28	maxeke	maxeke	PROPN
ajlm-1355	51	29	johannesburg	johannesburg	PROPN
ajlm-1355	51	30	academic	academic	ADJ
ajlm-1355	51	31	hospital	hospital	NOUN
ajlm-1355	51	32	in	in	ADP
ajlm-1355	51	33	february	february	PROPN
ajlm-1355	51	34	2019	2019	NUM
ajlm-1355	51	35	.	.	PUNCT
ajlm-1355	52	1	image	image	NOUN
ajlm-1355	52	2	shows	show	VERB
ajlm-1355	52	3	translocation	translocation	NOUN
ajlm-1355	52	4	t(8;14)(q24;q32	t(8;14)(q24;q32	NOUN
ajlm-1355	52	5	)	)	PUNCT
ajlm-1355	52	6	using	use	VERB
ajlm-1355	52	7	the	the	DET
ajlm-1355	52	8	vysis	vysis	NOUN
ajlm-1355	52	9	lsi	lsi	PROPN
ajlm-1355	52	10	myc	myc	PROPN
ajlm-1355	52	11	/	/	SYM
ajlm-1355	52	12	igh	igh	PROPN
ajlm-1355	52	13	/	/	SYM
ajlm-1355	52	14	cep8	cep8	PROPN
ajlm-1355	52	15	tri	tri	ADJ
ajlm-1355	52	16	-	-	ADJ
ajlm-1355	52	17	colour	colour	ADJ
ajlm-1355	52	18	dual	dual	ADJ
ajlm-1355	52	19	fusion	fusion	NOUN
ajlm-1355	52	20	probe	probe	NOUN
ajlm-1355	52	21	,	,	PUNCT
ajlm-1355	52	22	as	as	ADV
ajlm-1355	52	23	well	well	ADV
ajlm-1355	52	24	as	as	ADP
ajlm-1355	52	25	a	a	DET
ajlm-1355	52	26	2f1o1g2a	2f1o1g2a	NUM
ajlm-1355	52	27	pattern	pattern	NOUN
ajlm-1355	52	28	:	:	PUNCT
ajlm-1355	52	29	2	2	NUM
ajlm-1355	52	30	fusion	fusion	NOUN
ajlm-1355	52	31	,	,	PUNCT
ajlm-1355	52	32	1	1	NUM
ajlm-1355	52	33	orange	orange	ADJ
ajlm-1355	52	34	,	,	PUNCT
ajlm-1355	52	35	1	1	NUM
ajlm-1355	52	36	green	green	ADJ
ajlm-1355	52	37	,	,	PUNCT
ajlm-1355	52	38	2	2	NUM
ajlm-1355	52	39	aqua	aqua	NOUN
ajlm-1355	52	40	signals	signal	NOUN
ajlm-1355	52	41	.	.	PUNCT
ajlm-1355	53	1	the	the	DET
ajlm-1355	53	2	orange	orange	ADJ
ajlm-1355	53	3	,	,	PUNCT
ajlm-1355	53	4	green	green	ADJ
ajlm-1355	53	5	and	and	CCONJ
ajlm-1355	53	6	aqua	aqua	NOUN
ajlm-1355	53	7	signals	signal	NOUN
ajlm-1355	53	8	represent	represent	VERB
ajlm-1355	53	9	the	the	DET
ajlm-1355	53	10	myc	myc	PROPN
ajlm-1355	53	11	,	,	PUNCT
ajlm-1355	53	12	igh	igh	PROPN
ajlm-1355	53	13	and	and	CCONJ
ajlm-1355	53	14	centromere	centromere	ADJ
ajlm-1355	53	15	8	8	NUM
ajlm-1355	53	16	regions	region	NOUN
ajlm-1355	53	17	.	.	PUNCT
ajlm-1355	54	1	table	table	NOUN
ajlm-1355	54	2	1	1	NUM
ajlm-1355	54	3	:	:	PUNCT
ajlm-1355	54	4	 	 	SPACE
ajlm-1355	54	5	laboratory	laboratory	NOUN
ajlm-1355	54	6	results	result	NOUN
ajlm-1355	54	7	at	at	ADP
ajlm-1355	54	8	presentation	presentation	NOUN
ajlm-1355	54	9	of	of	ADP
ajlm-1355	54	10	a	a	DET
ajlm-1355	54	11	9	9	NUM
ajlm-1355	54	12	-	-	PUNCT
ajlm-1355	54	13	month	month	NOUN
ajlm-1355	54	14	-	-	PUNCT
ajlm-1355	54	15	old	old	ADJ
ajlm-1355	54	16	male	male	ADJ
ajlm-1355	54	17	patient	patient	NOUN
ajlm-1355	54	18	who	who	PRON
ajlm-1355	54	19	presented	present	VERB
ajlm-1355	54	20	to	to	ADP
ajlm-1355	54	21	the	the	DET
ajlm-1355	54	22	charlotte	charlotte	PROPN
ajlm-1355	54	23	maxeke	maxeke	PROPN
ajlm-1355	54	24	johannesburg	johannesburg	PROPN
ajlm-1355	54	25	academic	academic	ADJ
ajlm-1355	54	26	hospital	hospital	NOUN
ajlm-1355	54	27	in	in	ADP
ajlm-1355	54	28	february	february	PROPN
ajlm-1355	54	29	2019	2019	NUM
ajlm-1355	54	30	.	.	PUNCT
ajlm-1355	55	1	table	table	NOUN
ajlm-1355	55	2	2	2	NUM
ajlm-1355	55	3	:	:	PUNCT
ajlm-1355	55	4	 	 	SPACE
ajlm-1355	55	5	laboratory	laboratory	NOUN
ajlm-1355	55	6	results	result	NOUN
ajlm-1355	55	7	at	at	ADP
ajlm-1355	55	8	presentation	presentation	NOUN
ajlm-1355	55	9	of	of	ADP
ajlm-1355	55	10	a	a	DET
ajlm-1355	55	11	9	9	NUM
ajlm-1355	55	12	-	-	PUNCT
ajlm-1355	55	13	month	month	NOUN
ajlm-1355	55	14	-	-	PUNCT
ajlm-1355	55	15	old	old	ADJ
ajlm-1355	55	16	male	male	ADJ
ajlm-1355	55	17	patient	patient	NOUN
ajlm-1355	55	18	who	who	PRON
ajlm-1355	55	19	presented	present	VERB
ajlm-1355	55	20	to	to	ADP
ajlm-1355	55	21	the	the	DET
ajlm-1355	55	22	charlotte	charlotte	PROPN
ajlm-1355	55	23	maxeke	maxeke	PROPN
ajlm-1355	55	24	johannesburg	johannesburg	PROPN
ajlm-1355	55	25	academic	academic	ADJ
ajlm-1355	55	26	hospital	hospital	NOUN
ajlm-1355	55	27	in	in	ADP
ajlm-1355	55	28	february	february	PROPN
ajlm-1355	55	29	2019	2019	NUM
ajlm-1355	55	30	.	.	PUNCT
ajlm-1355	56	1	management	management	NOUN
ajlm-1355	56	2	and	and	CCONJ
ajlm-1355	56	3	outcomes	outcome	NOUN
ajlm-1355	56	4	the	the	DET
ajlm-1355	56	5	patient	patient	NOUN
ajlm-1355	56	6	was	be	AUX
ajlm-1355	56	7	initiated	initiate	VERB
ajlm-1355	56	8	on	on	ADP
ajlm-1355	56	9	a	a	DET
ajlm-1355	56	10	bll	bll	NOUN
ajlm-1355	56	11	regimen	regiman	NOUN
ajlm-1355	56	12	as	as	SCONJ
ajlm-1355	56	13	per	per	ADP
ajlm-1355	56	14	the	the	DET
ajlm-1355	56	15	fab	fab	NOUN
ajlm-1355	56	16	lmb	lmb	PROPN
ajlm-1355	56	17	95	95	NUM
ajlm-1355	56	18	protocol	protocol	NOUN
ajlm-1355	56	19	with	with	ADP
ajlm-1355	56	20	excellent	excellent	ADJ
ajlm-1355	56	21	clinical	clinical	ADJ
ajlm-1355	56	22	response.7	response.7	NOUN
ajlm-1355	56	23	there	there	PRON
ajlm-1355	56	24	was	be	VERB
ajlm-1355	56	25	complete	complete	ADJ
ajlm-1355	56	26	resolution	resolution	NOUN
ajlm-1355	56	27	of	of	ADP
ajlm-1355	56	28	the	the	DET
ajlm-1355	56	29	proptosis	proptosis	NOUN
ajlm-1355	56	30	and	and	CCONJ
ajlm-1355	56	31	the	the	DET
ajlm-1355	56	32	scalp	scalp	NOUN
ajlm-1355	56	33	masses	masse	NOUN
ajlm-1355	56	34	were	be	AUX
ajlm-1355	56	35	no	no	ADV
ajlm-1355	56	36	longer	long	ADV
ajlm-1355	56	37	clinically	clinically	ADV
ajlm-1355	56	38	evident	evident	ADJ
ajlm-1355	56	39	.	.	PUNCT
ajlm-1355	57	1	sadly	sadly	ADV
ajlm-1355	57	2	,	,	PUNCT
ajlm-1355	57	3	the	the	DET
ajlm-1355	57	4	patient	patient	NOUN
ajlm-1355	57	5	succumbed	succumb	VERB
ajlm-1355	57	6	to	to	ADP
ajlm-1355	57	7	neutropenic	neutropenic	ADJ
ajlm-1355	57	8	sepsis	sepsis	NOUN
ajlm-1355	57	9	six	six	NUM
ajlm-1355	57	10	months	month	NOUN
ajlm-1355	57	11	after	after	ADP
ajlm-1355	57	12	diagnosis	diagnosis	NOUN
ajlm-1355	57	13	.	.	PUNCT
ajlm-1355	58	1	discussion	discussion	NOUN
ajlm-1355	58	2	the	the	DET
ajlm-1355	58	3	co	co	NOUN
ajlm-1355	58	4	-	-	NOUN
ajlm-1355	58	5	existence	existence	NOUN
ajlm-1355	58	6	of	of	ADP
ajlm-1355	58	7	the	the	DET
ajlm-1355	58	8	translocation	translocation	NOUN
ajlm-1355	58	9	t(8;14	t(8;14	NOUN
ajlm-1355	58	10	)	)	PUNCT
ajlm-1355	58	11	or	or	CCONJ
ajlm-1355	58	12	variant	variant	NOUN
ajlm-1355	58	13	myc	myc	NOUN
ajlm-1355	58	14	translocation	translocation	NOUN
ajlm-1355	58	15	with	with	ADP
ajlm-1355	58	16	a	a	DET
ajlm-1355	58	17	precursor	precursor	NOUN
ajlm-1355	58	18	b	b	NOUN
ajlm-1355	58	19	-	-	PUNCT
ajlm-1355	58	20	cell	cell	NOUN
ajlm-1355	58	21	phenotype	phenotype	NOUN
ajlm-1355	58	22	in	in	ADP
ajlm-1355	58	23	an	an	DET
ajlm-1355	58	24	extranodal	extranodal	ADJ
ajlm-1355	58	25	malignancy	malignancy	NOUN
ajlm-1355	58	26	is	be	AUX
ajlm-1355	58	27	extremely	extremely	ADV
ajlm-1355	58	28	uncommon	uncommon	ADJ
ajlm-1355	58	29	and	and	CCONJ
ajlm-1355	58	30	has	have	AUX
ajlm-1355	58	31	been	be	AUX
ajlm-1355	58	32	reported	report	VERB
ajlm-1355	58	33	in	in	ADP
ajlm-1355	58	34	only	only	ADV
ajlm-1355	58	35	one	one	NUM
ajlm-1355	58	36	paediatric	paediatric	ADJ
ajlm-1355	58	37	and	and	CCONJ
ajlm-1355	58	38	one	one	NUM
ajlm-1355	58	39	adult	adult	NOUN
ajlm-1355	58	40	patient	patient	NOUN
ajlm-1355	58	41	in	in	ADP
ajlm-1355	58	42	the	the	DET
ajlm-1355	58	43	literature.3,4	literature.3,4	ADJ
ajlm-1355	58	44	these	these	DET
ajlm-1355	58	45	individuals	individual	NOUN
ajlm-1355	58	46	were	be	AUX
ajlm-1355	58	47	both	both	CCONJ
ajlm-1355	58	48	female	female	ADJ
ajlm-1355	58	49	and	and	CCONJ
ajlm-1355	58	50	had	have	VERB
ajlm-1355	58	51	no	no	DET
ajlm-1355	58	52	laboratory	laboratory	NOUN
ajlm-1355	58	53	evidence	evidence	NOUN
ajlm-1355	58	54	of	of	ADP
ajlm-1355	58	55	either	either	CCONJ
ajlm-1355	58	56	peripheral	peripheral	ADJ
ajlm-1355	58	57	blood	blood	NOUN
ajlm-1355	58	58	or	or	CCONJ
ajlm-1355	58	59	bone	bone	NOUN
ajlm-1355	58	60	marrow	marrow	NOUN
ajlm-1355	58	61	involvement	involvement	NOUN
ajlm-1355	58	62	at	at	ADP
ajlm-1355	58	63	presentation	presentation	NOUN
ajlm-1355	58	64	.	.	PUNCT
ajlm-1355	59	1	the	the	DET
ajlm-1355	59	2	youngest	young	ADJ
ajlm-1355	59	3	,	,	PUNCT
ajlm-1355	59	4	a	a	DET
ajlm-1355	59	5	5	5	NUM
ajlm-1355	59	6	-	-	PUNCT
ajlm-1355	59	7	year	year	NOUN
ajlm-1355	59	8	-	-	PUNCT
ajlm-1355	59	9	old	old	ADJ
ajlm-1355	59	10	,	,	PUNCT
ajlm-1355	59	11	presented	present	VERB
ajlm-1355	59	12	with	with	ADP
ajlm-1355	59	13	abdominal	abdominal	ADJ
ajlm-1355	59	14	,	,	PUNCT
ajlm-1355	59	15	orbital	orbital	ADJ
ajlm-1355	59	16	and	and	CCONJ
ajlm-1355	59	17	mandibular	mandibular	NOUN
ajlm-1355	59	18	masses.4	masses.4	PROPN
ajlm-1355	59	19	the	the	DET
ajlm-1355	59	20	second	second	ADJ
ajlm-1355	59	21	,	,	PUNCT
ajlm-1355	59	22	a	a	DET
ajlm-1355	59	23	64	64	NUM
ajlm-1355	59	24	-	-	PUNCT
ajlm-1355	59	25	year	year	NOUN
ajlm-1355	59	26	-	-	PUNCT
ajlm-1355	59	27	old	old	ADJ
ajlm-1355	59	28	,	,	PUNCT
ajlm-1355	59	29	had	have	VERB
ajlm-1355	59	30	multiple	multiple	ADJ
ajlm-1355	59	31	extranodal	extranodal	NOUN
ajlm-1355	59	32	lesions	lesion	NOUN
ajlm-1355	59	33	and	and	CCONJ
ajlm-1355	59	34	a	a	DET
ajlm-1355	59	35	chronic	chronic	ADJ
ajlm-1355	59	36	disease	disease	NOUN
ajlm-1355	59	37	course.3	course.3	PROPN
ajlm-1355	59	38	similarly	similarly	ADV
ajlm-1355	59	39	,	,	PUNCT
ajlm-1355	59	40	the	the	DET
ajlm-1355	59	41	clinical	clinical	ADJ
ajlm-1355	59	42	presentation	presentation	NOUN
ajlm-1355	59	43	of	of	ADP
ajlm-1355	59	44	our	our	PRON
ajlm-1355	59	45	patient	patient	NOUN
ajlm-1355	59	46	was	be	AUX
ajlm-1355	59	47	with	with	ADP
ajlm-1355	59	48	isolated	isolated	ADJ
ajlm-1355	59	49	extranodal	extranodal	NOUN
ajlm-1355	59	50	disease	disease	NOUN
ajlm-1355	59	51	.	.	PUNCT
ajlm-1355	60	1	this	this	DET
ajlm-1355	60	2	pattern	pattern	NOUN
ajlm-1355	60	3	of	of	ADP
ajlm-1355	60	4	involvement	involvement	NOUN
ajlm-1355	60	5	is	be	AUX
ajlm-1355	60	6	often	often	ADV
ajlm-1355	60	7	seen	see	VERB
ajlm-1355	60	8	in	in	ADP
ajlm-1355	60	9	burkitt	burkitt	PROPN
ajlm-1355	60	10	lymphoma	lymphoma	NOUN
ajlm-1355	60	11	and	and	CCONJ
ajlm-1355	60	12	thus	thus	ADV
ajlm-1355	60	13	formed	form	VERB
ajlm-1355	60	14	part	part	NOUN
ajlm-1355	60	15	of	of	ADP
ajlm-1355	60	16	the	the	DET
ajlm-1355	60	17	differential	differential	ADJ
ajlm-1355	60	18	diagnosis	diagnosis	NOUN
ajlm-1355	60	19	in	in	ADP
ajlm-1355	60	20	our	our	PRON
ajlm-1355	60	21	patient	patient	NOUN
ajlm-1355	60	22	.	.	PUNCT
ajlm-1355	61	1	laboratory	laboratory	NOUN
ajlm-1355	61	2	work	work	NOUN
ajlm-1355	61	3	up	up	ADP
ajlm-1355	61	4	demonstrated	demonstrate	VERB
ajlm-1355	61	5	the	the	DET
ajlm-1355	61	6	co	co	NOUN
ajlm-1355	61	7	-	-	NOUN
ajlm-1355	61	8	expression	expression	NOUN
ajlm-1355	61	9	of	of	ADP
ajlm-1355	61	10	cd19	cd19	PROPN
ajlm-1355	61	11	and	and	CCONJ
ajlm-1355	61	12	cd10	cd10	PROPN
ajlm-1355	61	13	by	by	ADP
ajlm-1355	61	14	the	the	DET
ajlm-1355	61	15	tumour	tumour	NOUN
ajlm-1355	61	16	,	,	PUNCT
ajlm-1355	61	17	with	with	ADP
ajlm-1355	61	18	no	no	DET
ajlm-1355	61	19	expression	expression	NOUN
ajlm-1355	61	20	of	of	ADP
ajlm-1355	61	21	cd34	cd34	PROPN
ajlm-1355	61	22	or	or	CCONJ
ajlm-1355	61	23	light	light	ADJ
ajlm-1355	61	24	chains	chain	NOUN
ajlm-1355	61	25	.	.	PUNCT
ajlm-1355	62	1	because	because	SCONJ
ajlm-1355	62	2	of	of	ADP
ajlm-1355	62	3	this	this	PRON
ajlm-1355	62	4	,	,	PUNCT
ajlm-1355	62	5	the	the	DET
ajlm-1355	62	6	expression	expression	NOUN
ajlm-1355	62	7	of	of	ADP
ajlm-1355	62	8	tdt	tdt	PROPN
ajlm-1355	62	9	was	be	AUX
ajlm-1355	62	10	assessed	assess	VERB
ajlm-1355	62	11	.	.	PUNCT
ajlm-1355	63	1	terminal	terminal	ADJ
ajlm-1355	63	2	deoxynucleotidyl	deoxynucleotidyl	NOUN
ajlm-1355	63	3	transferase	transferase	NOUN
ajlm-1355	63	4	is	be	AUX
ajlm-1355	63	5	a	a	DET
ajlm-1355	63	6	dna	dna	NOUN
ajlm-1355	63	7	polymerase	polymerase	NOUN
ajlm-1355	63	8	that	that	PRON
ajlm-1355	63	9	functions	function	VERB
ajlm-1355	63	10	to	to	PART
ajlm-1355	63	11	provide	provide	VERB
ajlm-1355	63	12	junctional	junctional	ADJ
ajlm-1355	63	13	diversity	diversity	NOUN
ajlm-1355	63	14	in	in	ADP
ajlm-1355	63	15	both	both	DET
ajlm-1355	63	16	b	b	NOUN
ajlm-1355	63	17	-	-	PUNCT
ajlm-1355	63	18	cell	cell	NOUN
ajlm-1355	63	19	and	and	CCONJ
ajlm-1355	63	20	t	t	NOUN
ajlm-1355	63	21	-	-	PUNCT
ajlm-1355	63	22	cell	cell	NOUN
ajlm-1355	63	23	receptor	receptor	NOUN
ajlm-1355	63	24	genes	gene	NOUN
ajlm-1355	63	25	at	at	ADP
ajlm-1355	63	26	the	the	DET
ajlm-1355	63	27	precursor	precursor	NOUN
ajlm-1355	63	28	cell	cell	NOUN
ajlm-1355	63	29	stage.8	stage.8	NOUN
ajlm-1355	63	30	it	it	PRON
ajlm-1355	63	31	is	be	AUX
ajlm-1355	63	32	a	a	DET
ajlm-1355	63	33	marker	marker	NOUN
ajlm-1355	63	34	of	of	ADP
ajlm-1355	63	35	immaturity	immaturity	NOUN
ajlm-1355	63	36	and	and	CCONJ
ajlm-1355	63	37	its	its	PRON
ajlm-1355	63	38	expression	expression	NOUN
ajlm-1355	63	39	in	in	ADP
ajlm-1355	63	40	mature	mature	ADJ
ajlm-1355	63	41	neoplasms	neoplasm	NOUN
ajlm-1355	63	42	such	such	ADJ
ajlm-1355	63	43	as	as	ADP
ajlm-1355	63	44	bll	bll	PROPN
ajlm-1355	63	45	would	would	AUX
ajlm-1355	63	46	be	be	AUX
ajlm-1355	63	47	aberrant	aberrant	ADJ
ajlm-1355	63	48	.	.	PUNCT
ajlm-1355	64	1	terminal	terminal	ADJ
ajlm-1355	64	2	deoxynucleotidyl	deoxynucleotidyl	PROPN
ajlm-1355	64	3	transferase	transferase	NOUN
ajlm-1355	64	4	was	be	AUX
ajlm-1355	64	5	found	find	VERB
ajlm-1355	64	6	to	to	PART
ajlm-1355	64	7	be	be	AUX
ajlm-1355	64	8	positive	positive	ADJ
ajlm-1355	64	9	in	in	ADP
ajlm-1355	64	10	~30	~30	NOUN
ajlm-1355	64	11	%	%	NOUN
ajlm-1355	64	12	–	–	PUNCT
ajlm-1355	64	13	40	40	NUM
ajlm-1355	64	14	%	%	NOUN
ajlm-1355	64	15	of	of	ADP
ajlm-1355	64	16	the	the	DET
ajlm-1355	64	17	tumour	tumour	NOUN
ajlm-1355	64	18	on	on	ADP
ajlm-1355	64	19	both	both	CCONJ
ajlm-1355	64	20	the	the	DET
ajlm-1355	64	21	fine	fine	ADJ
ajlm-1355	64	22	needle	needle	NOUN
ajlm-1355	64	23	aspiration	aspiration	NOUN
ajlm-1355	64	24	and	and	CCONJ
ajlm-1355	64	25	tru	tru	NOUN
ajlm-1355	64	26	-	-	PUNCT
ajlm-1355	64	27	cut	cut	VERB
ajlm-1355	64	28	biopsy	biopsy	NOUN
ajlm-1355	64	29	specimens	specimen	NOUN
ajlm-1355	64	30	.	.	PUNCT
ajlm-1355	65	1	while	while	SCONJ
ajlm-1355	65	2	these	these	DET
ajlm-1355	65	3	results	result	NOUN
ajlm-1355	65	4	pointed	point	VERB
ajlm-1355	65	5	towards	towards	ADP
ajlm-1355	65	6	a	a	DET
ajlm-1355	65	7	tumour	tumour	NOUN
ajlm-1355	65	8	at	at	ADP
ajlm-1355	65	9	a	a	DET
ajlm-1355	65	10	precursor	precursor	NOUN
ajlm-1355	65	11	cell	cell	NOUN
ajlm-1355	65	12	stage	stage	NOUN
ajlm-1355	65	13	of	of	ADP
ajlm-1355	65	14	development	development	NOUN
ajlm-1355	65	15	,	,	PUNCT
ajlm-1355	65	16	the	the	DET
ajlm-1355	65	17	s	s	NOUN
ajlm-1355	65	18	-	-	PUNCT
ajlm-1355	65	19	phase	phase	NOUN
ajlm-1355	65	20	fraction	fraction	NOUN
ajlm-1355	65	21	analysis	analysis	NOUN
ajlm-1355	65	22	found	find	VERB
ajlm-1355	65	23	the	the	DET
ajlm-1355	65	24	tumour	tumour	ADJ
ajlm-1355	65	25	proliferative	proliferative	ADJ
ajlm-1355	65	26	activity	activity	NOUN
ajlm-1355	65	27	to	to	PART
ajlm-1355	65	28	be	be	AUX
ajlm-1355	65	29	very	very	ADV
ajlm-1355	65	30	high	high	ADJ
ajlm-1355	65	31	.	.	PUNCT
ajlm-1355	66	1	this	this	DET
ajlm-1355	66	2	measurement	measurement	NOUN
ajlm-1355	66	3	is	be	AUX
ajlm-1355	66	4	performed	perform	VERB
ajlm-1355	66	5	by	by	ADP
ajlm-1355	66	6	flow	flow	NOUN
ajlm-1355	66	7	cytometry	cytometry	NOUN
ajlm-1355	66	8	and	and	CCONJ
ajlm-1355	66	9	uses	use	VERB
ajlm-1355	66	10	dna	dna	PROPN
ajlm-1355	66	11	content	content	NOUN
ajlm-1355	66	12	to	to	PART
ajlm-1355	66	13	determine	determine	VERB
ajlm-1355	66	14	the	the	DET
ajlm-1355	66	15	proportion	proportion	NOUN
ajlm-1355	66	16	of	of	ADP
ajlm-1355	66	17	cells	cell	NOUN
ajlm-1355	66	18	in	in	ADP
ajlm-1355	66	19	each	each	DET
ajlm-1355	66	20	phase	phase	NOUN
ajlm-1355	66	21	of	of	ADP
ajlm-1355	66	22	the	the	DET
ajlm-1355	66	23	cell	cell	NOUN
ajlm-1355	66	24	cycle	cycle	NOUN
ajlm-1355	66	25	.	.	PUNCT
ajlm-1355	67	1	studies	study	NOUN
ajlm-1355	67	2	performed	perform	VERB
ajlm-1355	67	3	at	at	ADP
ajlm-1355	67	4	our	our	PRON
ajlm-1355	67	5	centre	centre	NOUN
ajlm-1355	67	6	have	have	AUX
ajlm-1355	67	7	shown	show	VERB
ajlm-1355	67	8	the	the	DET
ajlm-1355	67	9	s	s	NOUN
ajlm-1355	67	10	-	-	PUNCT
ajlm-1355	67	11	phase	phase	NOUN
ajlm-1355	67	12	fraction	fraction	NOUN
ajlm-1355	67	13	of	of	ADP
ajlm-1355	67	14	b	b	NOUN
ajlm-1355	67	15	-	-	PUNCT
ajlm-1355	67	16	all	all	PRON
ajlm-1355	67	17	to	to	PART
ajlm-1355	67	18	be	be	AUX
ajlm-1355	67	19	characteristically	characteristically	ADV
ajlm-1355	67	20	around	around	ADP
ajlm-1355	67	21	10	10	NUM
ajlm-1355	67	22	,	,	PUNCT
ajlm-1355	67	23	whereas	whereas	SCONJ
ajlm-1355	67	24	a	a	DET
ajlm-1355	67	25	fraction	fraction	NOUN
ajlm-1355	67	26	of	of	ADP
ajlm-1355	67	27	more	more	ADJ
ajlm-1355	67	28	than	than	ADP
ajlm-1355	67	29	30	30	NUM
ajlm-1355	67	30	,	,	PUNCT
ajlm-1355	67	31	as	as	SCONJ
ajlm-1355	67	32	seen	see	VERB
ajlm-1355	67	33	in	in	ADP
ajlm-1355	67	34	our	our	PRON
ajlm-1355	67	35	patient	patient	NOUN
ajlm-1355	67	36	,	,	PUNCT
ajlm-1355	67	37	would	would	AUX
ajlm-1355	67	38	be	be	AUX
ajlm-1355	67	39	more	more	ADV
ajlm-1355	67	40	typical	typical	ADJ
ajlm-1355	67	41	of	of	ADP
ajlm-1355	67	42	bll.6	bll.6	PROPN
ajlm-1355	67	43	comparisons	comparison	NOUN
ajlm-1355	67	44	could	could	AUX
ajlm-1355	67	45	not	not	PART
ajlm-1355	67	46	be	be	AUX
ajlm-1355	67	47	made	make	VERB
ajlm-1355	67	48	with	with	ADP
ajlm-1355	67	49	the	the	DET
ajlm-1355	67	50	other	other	ADJ
ajlm-1355	67	51	cases	case	NOUN
ajlm-1355	67	52	in	in	ADP
ajlm-1355	67	53	the	the	DET
ajlm-1355	67	54	literature	literature	NOUN
ajlm-1355	67	55	as	as	SCONJ
ajlm-1355	67	56	s	s	NOUN
ajlm-1355	67	57	-	-	PUNCT
ajlm-1355	67	58	phase	phase	NOUN
ajlm-1355	67	59	fraction	fraction	NOUN
ajlm-1355	67	60	analysis	analysis	NOUN
ajlm-1355	67	61	was	be	AUX
ajlm-1355	67	62	not	not	PART
ajlm-1355	67	63	reported	report	VERB
ajlm-1355	67	64	.	.	PUNCT
ajlm-1355	68	1	the	the	DET
ajlm-1355	68	2	ki67	ki67	PROPN
ajlm-1355	68	3	index	index	NOUN
ajlm-1355	68	4	detects	detect	VERB
ajlm-1355	68	5	a	a	DET
ajlm-1355	68	6	protein	protein	NOUN
ajlm-1355	68	7	associated	associate	VERB
ajlm-1355	68	8	with	with	ADP
ajlm-1355	68	9	cellular	cellular	ADJ
ajlm-1355	68	10	proliferation	proliferation	NOUN
ajlm-1355	68	11	,	,	PUNCT
ajlm-1355	68	12	which	which	PRON
ajlm-1355	68	13	is	be	AUX
ajlm-1355	68	14	present	present	ADJ
ajlm-1355	68	15	in	in	ADP
ajlm-1355	68	16	all	all	DET
ajlm-1355	68	17	active	active	ADJ
ajlm-1355	68	18	stages	stage	NOUN
ajlm-1355	68	19	of	of	ADP
ajlm-1355	68	20	the	the	DET
ajlm-1355	68	21	cell	cell	NOUN
ajlm-1355	68	22	cycle	cycle	NOUN
ajlm-1355	68	23	.	.	PUNCT
ajlm-1355	69	1	given	give	VERB
ajlm-1355	69	2	that	that	SCONJ
ajlm-1355	69	3	the	the	DET
ajlm-1355	69	4	ki67	ki67	PROPN
ajlm-1355	69	5	index	index	NOUN
ajlm-1355	69	6	and	and	CCONJ
ajlm-1355	69	7	s	s	NOUN
ajlm-1355	69	8	-	-	PUNCT
ajlm-1355	69	9	phase	phase	NOUN
ajlm-1355	69	10	analysis	analysis	NOUN
ajlm-1355	69	11	measure	measure	VERB
ajlm-1355	69	12	different	different	ADJ
ajlm-1355	69	13	aspects	aspect	NOUN
ajlm-1355	69	14	of	of	ADP
ajlm-1355	69	15	proliferation	proliferation	NOUN
ajlm-1355	69	16	,	,	PUNCT
ajlm-1355	69	17	these	these	DET
ajlm-1355	69	18	parameters	parameter	NOUN
ajlm-1355	69	19	are	be	AUX
ajlm-1355	69	20	not	not	PART
ajlm-1355	69	21	always	always	ADV
ajlm-1355	69	22	comparable	comparable	ADJ
ajlm-1355	69	23	.	.	PUNCT
ajlm-1355	70	1	notably	notably	ADV
ajlm-1355	70	2	,	,	PUNCT
ajlm-1355	70	3	the	the	DET
ajlm-1355	70	4	ki67	ki67	PROPN
ajlm-1355	70	5	index	index	NOUN
ajlm-1355	70	6	is	be	AUX
ajlm-1355	70	7	unhelpful	unhelpful	ADJ
ajlm-1355	70	8	in	in	ADP
ajlm-1355	70	9	distinguishing	distinguish	VERB
ajlm-1355	70	10	b	b	X
ajlm-1355	70	11	-	-	PUNCT
ajlm-1355	70	12	all	all	PRON
ajlm-1355	70	13	and	and	CCONJ
ajlm-1355	70	14	bll	bll	NOUN
ajlm-1355	70	15	as	as	SCONJ
ajlm-1355	70	16	values	value	NOUN
ajlm-1355	70	17	of	of	ADP
ajlm-1355	70	18	over	over	ADP
ajlm-1355	70	19	95	95	NUM
ajlm-1355	70	20	%	%	NOUN
ajlm-1355	70	21	can	can	AUX
ajlm-1355	70	22	be	be	AUX
ajlm-1355	70	23	anticipated	anticipate	VERB
ajlm-1355	70	24	in	in	ADP
ajlm-1355	70	25	both.6	both.6	PROPN
ajlm-1355	70	26	despite	despite	SCONJ
ajlm-1355	70	27	the	the	DET
ajlm-1355	70	28	conflicting	conflicting	ADJ
ajlm-1355	70	29	laboratory	laboratory	NOUN
ajlm-1355	70	30	findings	finding	NOUN
ajlm-1355	70	31	in	in	ADP
ajlm-1355	70	32	our	our	PRON
ajlm-1355	70	33	patient	patient	NOUN
ajlm-1355	70	34	,	,	PUNCT
ajlm-1355	70	35	the	the	DET
ajlm-1355	70	36	high	high	ADJ
ajlm-1355	70	37	s	s	NOUN
ajlm-1355	70	38	-	-	PUNCT
ajlm-1355	70	39	phase	phase	NOUN
ajlm-1355	70	40	fraction	fraction	NOUN
ajlm-1355	70	41	in	in	ADP
ajlm-1355	70	42	the	the	DET
ajlm-1355	70	43	context	context	NOUN
ajlm-1355	70	44	of	of	ADP
ajlm-1355	70	45	extranodal	extranodal	NOUN
ajlm-1355	70	46	disease	disease	NOUN
ajlm-1355	70	47	prompted	prompt	VERB
ajlm-1355	70	48	the	the	DET
ajlm-1355	70	49	testing	testing	NOUN
ajlm-1355	70	50	for	for	ADP
ajlm-1355	70	51	,	,	PUNCT
ajlm-1355	70	52	and	and	CCONJ
ajlm-1355	70	53	confirmation	confirmation	NOUN
ajlm-1355	70	54	of	of	ADP
ajlm-1355	70	55	,	,	PUNCT
ajlm-1355	70	56	the	the	DET
ajlm-1355	70	57	translocation	translocation	NOUN
ajlm-1355	70	58	t(8;14	t(8;14	PROPN
ajlm-1355	70	59	)	)	PUNCT
ajlm-1355	70	60	.	.	PUNCT
ajlm-1355	71	1	b	b	X
ajlm-1355	71	2	-	-	PUNCT
ajlm-1355	71	3	cell	cell	NOUN
ajlm-1355	71	4	lymphoma	lymphoma	NOUN
ajlm-1355	71	5	2	2	NUM
ajlm-1355	71	6	(	(	PUNCT
ajlm-1355	71	7	bcl2	bcl2	NOUN
ajlm-1355	71	8	)	)	PUNCT
ajlm-1355	71	9	expression	expression	NOUN
ajlm-1355	71	10	is	be	AUX
ajlm-1355	71	11	typically	typically	ADV
ajlm-1355	71	12	seen	see	VERB
ajlm-1355	71	13	in	in	ADP
ajlm-1355	71	14	acute	acute	ADJ
ajlm-1355	71	15	lymphoblastic	lymphoblastic	ADJ
ajlm-1355	71	16	leukaemia	leukaemia	NOUN
ajlm-1355	71	17	and	and	CCONJ
ajlm-1355	71	18	the	the	DET
ajlm-1355	71	19	possibility	possibility	NOUN
ajlm-1355	71	20	of	of	ADP
ajlm-1355	71	21	a	a	DET
ajlm-1355	71	22	double	double	ADJ
ajlm-1355	71	23	-	-	PUNCT
ajlm-1355	71	24	hit	hit	VERB
ajlm-1355	71	25	lymphoma	lymphoma	NOUN
ajlm-1355	71	26	was	be	AUX
ajlm-1355	71	27	excluded	exclude	VERB
ajlm-1355	71	28	by	by	ADP
ajlm-1355	71	29	the	the	DET
ajlm-1355	71	30	presence	presence	NOUN
ajlm-1355	71	31	of	of	ADP
ajlm-1355	71	32	tdt.2	tdt.2	PROPN
ajlm-1355	71	33	s	s	NOUN
ajlm-1355	71	34	-	-	PUNCT
ajlm-1355	71	35	phase	phase	NOUN
ajlm-1355	71	36	fraction	fraction	NOUN
ajlm-1355	71	37	analysis	analysis	NOUN
ajlm-1355	71	38	may	may	AUX
ajlm-1355	71	39	therefore	therefore	ADV
ajlm-1355	71	40	serve	serve	VERB
ajlm-1355	71	41	as	as	ADP
ajlm-1355	71	42	an	an	DET
ajlm-1355	71	43	early	early	ADJ
ajlm-1355	71	44	indicator	indicator	NOUN
ajlm-1355	71	45	of	of	ADP
ajlm-1355	71	46	this	this	DET
ajlm-1355	71	47	disease	disease	NOUN
ajlm-1355	71	48	entity	entity	NOUN
ajlm-1355	71	49	,	,	PUNCT
ajlm-1355	71	50	albeit	albeit	SCONJ
ajlm-1355	71	51	further	further	ADJ
ajlm-1355	71	52	investigation	investigation	NOUN
ajlm-1355	71	53	of	of	ADP
ajlm-1355	71	54	its	its	PRON
ajlm-1355	71	55	clinical	clinical	ADJ
ajlm-1355	71	56	utility	utility	NOUN
ajlm-1355	71	57	is	be	AUX
ajlm-1355	71	58	required	require	VERB
ajlm-1355	71	59	.	.	PUNCT
ajlm-1355	72	1	in	in	ADP
ajlm-1355	72	2	summary	summary	NOUN
ajlm-1355	72	3	,	,	PUNCT
ajlm-1355	72	4	a	a	DET
ajlm-1355	72	5	combination	combination	NOUN
ajlm-1355	72	6	of	of	ADP
ajlm-1355	72	7	diagnostic	diagnostic	ADJ
ajlm-1355	72	8	modalities	modality	NOUN
ajlm-1355	72	9	with	with	ADP
ajlm-1355	72	10	evaluation	evaluation	NOUN
ajlm-1355	72	11	by	by	ADP
ajlm-1355	72	12	a	a	DET
ajlm-1355	72	13	multidisciplinary	multidisciplinary	ADJ
ajlm-1355	72	14	team	team	NOUN
ajlm-1355	72	15	is	be	AUX
ajlm-1355	72	16	required	require	VERB
ajlm-1355	72	17	to	to	PART
ajlm-1355	72	18	confirm	confirm	VERB
ajlm-1355	72	19	this	this	DET
ajlm-1355	72	20	rare	rare	ADJ
ajlm-1355	72	21	entity	entity	NOUN
ajlm-1355	72	22	.	.	PUNCT
ajlm-1355	73	1	we	we	PRON
ajlm-1355	73	2	propose	propose	VERB
ajlm-1355	73	3	a	a	DET
ajlm-1355	73	4	laboratory	laboratory	NOUN
ajlm-1355	73	5	approach	approach	NOUN
ajlm-1355	73	6	to	to	ADP
ajlm-1355	73	7	the	the	DET
ajlm-1355	73	8	diagnosis	diagnosis	NOUN
ajlm-1355	73	9	of	of	ADP
ajlm-1355	73	10	lymphomas	lymphoma	NOUN
ajlm-1355	73	11	with	with	ADP
ajlm-1355	73	12	features	feature	NOUN
ajlm-1355	73	13	of	of	ADP
ajlm-1355	73	14	b	b	X
ajlm-1355	73	15	-	-	PUNCT
ajlm-1355	73	16	all	all	PRON
ajlm-1355	73	17	and	and	CCONJ
ajlm-1355	73	18	bll	bll	PROPN
ajlm-1355	73	19	(	(	PUNCT
ajlm-1355	73	20	figure	figure	NOUN
ajlm-1355	73	21	4	4	NUM
ajlm-1355	73	22	)	)	PUNCT
ajlm-1355	73	23	.	.	PUNCT
ajlm-1355	74	1	figure	figure	VERB
ajlm-1355	74	2	4	4	NUM
ajlm-1355	74	3	:	:	PUNCT
ajlm-1355	74	4	laboratory	laboratory	NOUN
ajlm-1355	74	5	approach	approach	NOUN
ajlm-1355	74	6	to	to	ADP
ajlm-1355	74	7	the	the	DET
ajlm-1355	74	8	diagnosis	diagnosis	NOUN
ajlm-1355	74	9	of	of	ADP
ajlm-1355	74	10	lymphoma	lymphoma	NOUN
ajlm-1355	74	11	with	with	ADP
ajlm-1355	74	12	features	feature	NOUN
ajlm-1355	74	13	of	of	ADP
ajlm-1355	74	14	precursor	precursor	NOUN
ajlm-1355	74	15	b	b	NOUN
ajlm-1355	74	16	-	-	PUNCT
ajlm-1355	74	17	lymphoblastic	lymphoblastic	ADJ
ajlm-1355	74	18	leukaemia	leukaemia	NOUN
ajlm-1355	74	19	or	or	CCONJ
ajlm-1355	74	20	lymphoma	lymphoma	NOUN
ajlm-1355	74	21	and	and	CCONJ
ajlm-1355	74	22	burkitt	burkitt	PROPN
ajlm-1355	74	23	leukaemia	leukaemia	NOUN
ajlm-1355	74	24	or	or	CCONJ
ajlm-1355	74	25	lymphoma	lymphoma	NOUN
ajlm-1355	74	26	.	.	PUNCT
ajlm-1355	75	1	the	the	DET
ajlm-1355	75	2	therapeutic	therapeutic	ADJ
ajlm-1355	75	3	management	management	NOUN
ajlm-1355	75	4	of	of	ADP
ajlm-1355	75	5	bll	bll	PROPN
ajlm-1355	75	6	differs	differ	VERB
ajlm-1355	75	7	significantly	significantly	ADV
ajlm-1355	75	8	from	from	ADP
ajlm-1355	75	9	b	b	X
ajlm-1355	75	10	-	-	PUNCT
ajlm-1355	75	11	all	all	PRON
ajlm-1355	75	12	.	.	PUNCT
ajlm-1355	76	1	the	the	DET
ajlm-1355	76	2	former	former	ADJ
ajlm-1355	76	3	requires	require	VERB
ajlm-1355	76	4	high	high	ADJ
ajlm-1355	76	5	-	-	PUNCT
ajlm-1355	76	6	intensity	intensity	NOUN
ajlm-1355	76	7	pulsed	pulse	VERB
ajlm-1355	76	8	chemotherapy	chemotherapy	NOUN
ajlm-1355	76	9	that	that	PRON
ajlm-1355	76	10	is	be	AUX
ajlm-1355	76	11	tailored	tailor	VERB
ajlm-1355	76	12	to	to	ADP
ajlm-1355	76	13	the	the	DET
ajlm-1355	76	14	high	high	ADJ
ajlm-1355	76	15	proliferative	proliferative	ADJ
ajlm-1355	76	16	rate	rate	NOUN
ajlm-1355	76	17	of	of	ADP
ajlm-1355	76	18	the	the	DET
ajlm-1355	76	19	tumour	tumour	NOUN
ajlm-1355	76	20	.	.	PUNCT
ajlm-1355	77	1	furthermore	furthermore	ADV
ajlm-1355	77	2	,	,	PUNCT
ajlm-1355	77	3	the	the	DET
ajlm-1355	77	4	duration	duration	NOUN
ajlm-1355	77	5	of	of	ADP
ajlm-1355	77	6	therapy	therapy	NOUN
ajlm-1355	77	7	is	be	AUX
ajlm-1355	77	8	shorter	short	ADJ
ajlm-1355	77	9	as	as	SCONJ
ajlm-1355	77	10	compared	compare	VERB
ajlm-1355	77	11	to	to	ADP
ajlm-1355	77	12	the	the	DET
ajlm-1355	77	13	extended	extended	ADJ
ajlm-1355	77	14	maintenance	maintenance	NOUN
ajlm-1355	77	15	used	use	VERB
ajlm-1355	77	16	in	in	ADP
ajlm-1355	77	17	b	b	NOUN
ajlm-1355	77	18	-	-	PROPN
ajlm-1355	77	19	all.7	all.7	NOUN
ajlm-1355	77	20	our	our	PRON
ajlm-1355	77	21	patient	patient	NOUN
ajlm-1355	77	22	was	be	AUX
ajlm-1355	77	23	instituted	institute	VERB
ajlm-1355	77	24	on	on	ADP
ajlm-1355	77	25	a	a	DET
ajlm-1355	77	26	bll	bll	PROPN
ajlm-1355	77	27	treatment	treatment	NOUN
ajlm-1355	77	28	protocol	protocol	NOUN
ajlm-1355	77	29	,	,	PUNCT
ajlm-1355	77	30	in	in	ADP
ajlm-1355	77	31	line	line	NOUN
ajlm-1355	77	32	with	with	ADP
ajlm-1355	77	33	the	the	DET
ajlm-1355	77	34	therapeutic	therapeutic	ADJ
ajlm-1355	77	35	approach	approach	NOUN
ajlm-1355	77	36	described	describe	VERB
ajlm-1355	77	37	in	in	ADP
ajlm-1355	77	38	the	the	DET
ajlm-1355	77	39	literature.1,4,5	literature.1,4,5	NOUN
ajlm-1355	77	40	there	there	PRON
ajlm-1355	77	41	are	be	VERB
ajlm-1355	77	42	however	however	ADV
ajlm-1355	77	43	limited	limited	ADJ
ajlm-1355	77	44	cases	case	NOUN
ajlm-1355	77	45	and	and	CCONJ
ajlm-1355	77	46	minimal	minimal	ADJ
ajlm-1355	77	47	long	long	ADJ
ajlm-1355	77	48	-	-	PUNCT
ajlm-1355	77	49	term	term	NOUN
ajlm-1355	77	50	follow	follow	NOUN
ajlm-1355	77	51	-	-	PUNCT
ajlm-1355	77	52	up	up	ADP
ajlm-1355	77	53	data	datum	NOUN
ajlm-1355	77	54	from	from	ADP
ajlm-1355	77	55	which	which	PRON
ajlm-1355	77	56	meaningful	meaningful	ADJ
ajlm-1355	77	57	conclusions	conclusion	NOUN
ajlm-1355	77	58	can	can	AUX
ajlm-1355	77	59	be	be	AUX
ajlm-1355	77	60	drawn	draw	VERB
ajlm-1355	77	61	.	.	PUNCT
ajlm-1355	78	1	on	on	ADP
ajlm-1355	78	2	a	a	DET
ajlm-1355	78	3	molecular	molecular	ADJ
ajlm-1355	78	4	level	level	NOUN
ajlm-1355	78	5	,	,	PUNCT
ajlm-1355	78	6	there	there	PRON
ajlm-1355	78	7	is	be	VERB
ajlm-1355	78	8	a	a	DET
ajlm-1355	78	9	lack	lack	NOUN
ajlm-1355	78	10	of	of	ADP
ajlm-1355	78	11	consensus	consensus	NOUN
ajlm-1355	78	12	as	as	ADP
ajlm-1355	78	13	to	to	ADP
ajlm-1355	78	14	whether	whether	SCONJ
ajlm-1355	78	15	this	this	DET
ajlm-1355	78	16	entity	entity	NOUN
ajlm-1355	78	17	represents	represent	VERB
ajlm-1355	78	18	a	a	DET
ajlm-1355	78	19	precursor	precursor	NOUN
ajlm-1355	78	20	b	b	NOUN
ajlm-1355	78	21	-	-	NOUN
ajlm-1355	78	22	cell	cell	NOUN
ajlm-1355	78	23	at	at	ADP
ajlm-1355	78	24	an	an	DET
ajlm-1355	78	25	intermediate	intermediate	ADJ
ajlm-1355	78	26	stage	stage	NOUN
ajlm-1355	78	27	of	of	ADP
ajlm-1355	78	28	maturation	maturation	NOUN
ajlm-1355	78	29	and	and	CCONJ
ajlm-1355	78	30	with	with	ADP
ajlm-1355	78	31	aberrant	aberrant	ADJ
ajlm-1355	78	32	myc	myc	NOUN
ajlm-1355	78	33	expression	expression	NOUN
ajlm-1355	78	34	,	,	PUNCT
ajlm-1355	78	35	or	or	CCONJ
ajlm-1355	78	36	a	a	DET
ajlm-1355	78	37	mature	mature	ADJ
ajlm-1355	78	38	b	b	NOUN
ajlm-1355	78	39	-	-	NOUN
ajlm-1355	78	40	cell	cell	NOUN
ajlm-1355	78	41	with	with	ADP
ajlm-1355	78	42	a	a	DET
ajlm-1355	78	43	less	less	ADV
ajlm-1355	78	44	differentiated	differentiated	ADJ
ajlm-1355	78	45	immunophenotype	immunophenotype	NOUN
ajlm-1355	78	46	.	.	PUNCT
ajlm-1355	79	1	furthermore	furthermore	ADV
ajlm-1355	79	2	,	,	PUNCT
ajlm-1355	79	3	questions	question	NOUN
ajlm-1355	79	4	have	have	AUX
ajlm-1355	79	5	been	be	AUX
ajlm-1355	79	6	raised	raise	VERB
ajlm-1355	79	7	as	as	ADP
ajlm-1355	79	8	to	to	ADP
ajlm-1355	79	9	whether	whether	SCONJ
ajlm-1355	79	10	or	or	CCONJ
ajlm-1355	79	11	not	not	PART
ajlm-1355	79	12	the	the	DET
ajlm-1355	79	13	presence	presence	NOUN
ajlm-1355	79	14	of	of	ADP
ajlm-1355	79	15	the	the	DET
ajlm-1355	79	16	translocation	translocation	NOUN
ajlm-1355	79	17	t(8;14	t(8;14	NOUN
ajlm-1355	79	18	)	)	PUNCT
ajlm-1355	79	19	translates	translate	VERB
ajlm-1355	79	20	into	into	ADP
ajlm-1355	79	21	an	an	DET
ajlm-1355	79	22	actual	actual	ADJ
ajlm-1355	79	23	proliferation	proliferation	NOUN
ajlm-1355	79	24	advantage	advantage	NOUN
ajlm-1355	79	25	.	.	PUNCT
ajlm-1355	80	1	in	in	ADP
ajlm-1355	80	2	an	an	DET
ajlm-1355	80	3	attempt	attempt	NOUN
ajlm-1355	80	4	to	to	PART
ajlm-1355	80	5	address	address	VERB
ajlm-1355	80	6	these	these	DET
ajlm-1355	80	7	questions	question	NOUN
ajlm-1355	80	8	,	,	PUNCT
ajlm-1355	80	9	one	one	NUM
ajlm-1355	80	10	study	study	NOUN
ajlm-1355	80	11	analysed	analyse	VERB
ajlm-1355	80	12	the	the	DET
ajlm-1355	80	13	molecular	molecular	ADJ
ajlm-1355	80	14	characteristics	characteristic	NOUN
ajlm-1355	80	15	of	of	ADP
ajlm-1355	80	16	neoplasms	neoplasm	NOUN
ajlm-1355	80	17	positive	positive	ADJ
ajlm-1355	80	18	for	for	ADP
ajlm-1355	80	19	ig	ig	PROPN
ajlm-1355	80	20	-	-	PUNCT
ajlm-1355	80	21	myc	myc	NOUN
ajlm-1355	80	22	rearrangement	rearrangement	NOUN
ajlm-1355	80	23	and	and	CCONJ
ajlm-1355	80	24	with	with	ADP
ajlm-1355	80	25	precursor	precursor	NOUN
ajlm-1355	80	26	b	b	NOUN
ajlm-1355	80	27	-	-	PUNCT
ajlm-1355	80	28	cell	cell	NOUN
ajlm-1355	80	29	phenotype	phenotype	NOUN
ajlm-1355	80	30	in	in	ADP
ajlm-1355	80	31	12	12	NUM
ajlm-1355	80	32	patients	patient	NOUN
ajlm-1355	80	33	.	.	PUNCT
ajlm-1355	81	1	aberrant	aberrant	ADJ
ajlm-1355	81	2	variable	variable	ADJ
ajlm-1355	81	3	diversity	diversity	NOUN
ajlm-1355	81	4	joining	join	VERB
ajlm-1355	81	5	recombination	recombination	NOUN
ajlm-1355	81	6	was	be	AUX
ajlm-1355	81	7	shown	show	VERB
ajlm-1355	81	8	in	in	ADP
ajlm-1355	81	9	five	five	NUM
ajlm-1355	81	10	patients	patient	NOUN
ajlm-1355	81	11	and	and	CCONJ
ajlm-1355	81	12	activating	activate	VERB
ajlm-1355	81	13	nand	nand	NOUN
ajlm-1355	81	14	k	k	PROPN
ajlm-1355	81	15	-	-	PUNCT
ajlm-1355	81	16	ras	ras	ADJ
ajlm-1355	81	17	mutations	mutation	NOUN
ajlm-1355	81	18	were	be	AUX
ajlm-1355	81	19	detected	detect	VERB
ajlm-1355	81	20	in	in	ADP
ajlm-1355	81	21	seven	seven	NUM
ajlm-1355	81	22	;	;	PUNCT
ajlm-1355	81	23	all	all	DET
ajlm-1355	81	24	neoplasms	neoplasm	NOUN
ajlm-1355	81	25	had	have	VERB
ajlm-1355	81	26	a	a	DET
ajlm-1355	81	27	dna	dna	PROPN
ajlm-1355	81	28	methylation	methylation	NOUN
ajlm-1355	81	29	profile	profile	NOUN
ajlm-1355	81	30	that	that	PRON
ajlm-1355	81	31	clustered	cluster	VERB
ajlm-1355	81	32	with	with	ADP
ajlm-1355	81	33	that	that	PRON
ajlm-1355	81	34	of	of	ADP
ajlm-1355	81	35	precursor	precursor	NOUN
ajlm-1355	81	36	b	b	NOUN
ajlm-1355	81	37	-	-	PUNCT
ajlm-1355	81	38	cells	cell	NOUN
ajlm-1355	81	39	.	.	PUNCT
ajlm-1355	82	1	in	in	ADP
ajlm-1355	82	2	light	light	NOUN
ajlm-1355	82	3	of	of	ADP
ajlm-1355	82	4	these	these	DET
ajlm-1355	82	5	findings	finding	NOUN
ajlm-1355	82	6	,	,	PUNCT
ajlm-1355	82	7	the	the	DET
ajlm-1355	82	8	authors	author	NOUN
ajlm-1355	82	9	of	of	ADP
ajlm-1355	82	10	the	the	DET
ajlm-1355	82	11	study	study	NOUN
ajlm-1355	82	12	posed	pose	VERB
ajlm-1355	82	13	the	the	DET
ajlm-1355	82	14	question	question	NOUN
ajlm-1355	82	15	as	as	ADP
ajlm-1355	82	16	to	to	ADP
ajlm-1355	82	17	whether	whether	SCONJ
ajlm-1355	82	18	or	or	CCONJ
ajlm-1355	82	19	not	not	PART
ajlm-1355	82	20	cases	case	NOUN
ajlm-1355	82	21	with	with	ADP
ajlm-1355	82	22	myc	myc	PROPN
ajlm-1355	82	23	rearrangement	rearrangement	PROPN
ajlm-1355	82	24	better	well	ADV
ajlm-1355	82	25	fit	fit	VERB
ajlm-1355	82	26	a	a	DET
ajlm-1355	82	27	b	b	NOUN
ajlm-1355	82	28	-	-	PUNCT
ajlm-1355	82	29	all	all	DET
ajlm-1355	82	30	profile.9	profile.9	NOUN
ajlm-1355	82	31	what	what	PRON
ajlm-1355	82	32	is	be	AUX
ajlm-1355	82	33	apparent	apparent	ADJ
ajlm-1355	82	34	from	from	ADP
ajlm-1355	82	35	the	the	DET
ajlm-1355	82	36	literature	literature	NOUN
ajlm-1355	82	37	is	be	AUX
ajlm-1355	82	38	that	that	SCONJ
ajlm-1355	82	39	further	further	ADJ
ajlm-1355	82	40	studies	study	NOUN
ajlm-1355	82	41	are	be	AUX
ajlm-1355	82	42	required	require	VERB
ajlm-1355	82	43	into	into	ADP
ajlm-1355	82	44	the	the	DET
ajlm-1355	82	45	molecular	molecular	ADJ
ajlm-1355	82	46	behaviour	behaviour	NOUN
ajlm-1355	82	47	of	of	ADP
ajlm-1355	82	48	this	this	DET
ajlm-1355	82	49	entity	entity	NOUN
ajlm-1355	82	50	to	to	PART
ajlm-1355	82	51	determine	determine	VERB
ajlm-1355	82	52	the	the	DET
ajlm-1355	82	53	prognostic	prognostic	ADJ
ajlm-1355	82	54	implications	implication	NOUN
ajlm-1355	82	55	and	and	CCONJ
ajlm-1355	82	56	best	good	ADJ
ajlm-1355	82	57	therapy	therapy	NOUN
ajlm-1355	82	58	.	.	PUNCT
ajlm-1355	83	1	conclusion	conclusion	NOUN
ajlm-1355	83	2	leukaemia	leukaemia	NOUN
ajlm-1355	83	3	or	or	CCONJ
ajlm-1355	83	4	lymphoma	lymphoma	NOUN
ajlm-1355	83	5	with	with	ADP
ajlm-1355	83	6	translocation	translocation	NOUN
ajlm-1355	83	7	t(8;14	t(8;14	PROPN
ajlm-1355	83	8	)	)	PUNCT
ajlm-1355	83	9	or	or	CCONJ
ajlm-1355	83	10	variant	variant	NOUN
ajlm-1355	83	11	myc	myc	NOUN
ajlm-1355	83	12	translocation	translocation	NOUN
ajlm-1355	83	13	and	and	CCONJ
ajlm-1355	83	14	precursor	precursor	NOUN
ajlm-1355	83	15	b	b	NOUN
ajlm-1355	83	16	-	-	PUNCT
ajlm-1355	83	17	cell	cell	NOUN
ajlm-1355	83	18	phenotype	phenotype	NOUN
ajlm-1355	83	19	is	be	AUX
ajlm-1355	83	20	a	a	DET
ajlm-1355	83	21	rare	rare	ADJ
ajlm-1355	83	22	entity	entity	NOUN
ajlm-1355	83	23	with	with	ADP
ajlm-1355	83	24	varied	varied	ADJ
ajlm-1355	83	25	clinical	clinical	ADJ
ajlm-1355	83	26	presentation	presentation	NOUN
ajlm-1355	83	27	.	.	PUNCT
ajlm-1355	84	1	awareness	awareness	NOUN
ajlm-1355	84	2	of	of	ADP
ajlm-1355	84	3	this	this	DET
ajlm-1355	84	4	entity	entity	NOUN
ajlm-1355	84	5	and	and	CCONJ
ajlm-1355	84	6	a	a	DET
ajlm-1355	84	7	high	high	ADJ
ajlm-1355	84	8	index	index	NOUN
ajlm-1355	84	9	of	of	ADP
ajlm-1355	84	10	suspicion	suspicion	NOUN
ajlm-1355	84	11	are	be	AUX
ajlm-1355	84	12	required	require	VERB
ajlm-1355	84	13	by	by	ADP
ajlm-1355	84	14	both	both	DET
ajlm-1355	84	15	clinicians	clinician	NOUN
ajlm-1355	84	16	(	(	PUNCT
ajlm-1355	84	17	haematologists	haematologist	NOUN
ajlm-1355	84	18	,	,	PUNCT
ajlm-1355	84	19	oncologists	oncologist	NOUN
ajlm-1355	84	20	)	)	PUNCT
ajlm-1355	84	21	and	and	CCONJ
ajlm-1355	84	22	pathologists	pathologist	NOUN
ajlm-1355	84	23	to	to	PART
ajlm-1355	84	24	prevent	prevent	VERB
ajlm-1355	84	25	a	a	DET
ajlm-1355	84	26	misdiagnosis	misdiagnosis	NOUN
ajlm-1355	84	27	.	.	PUNCT
ajlm-1355	85	1	further	further	ADJ
ajlm-1355	85	2	studies	study	NOUN
ajlm-1355	85	3	into	into	ADP
ajlm-1355	85	4	the	the	DET
ajlm-1355	85	5	molecular	molecular	ADJ
ajlm-1355	85	6	and	and	CCONJ
ajlm-1355	85	7	clinical	clinical	ADJ
ajlm-1355	85	8	behaviour	behaviour	NOUN
ajlm-1355	85	9	of	of	ADP
ajlm-1355	85	10	this	this	DET
ajlm-1355	85	11	tumour	tumour	NOUN
ajlm-1355	85	12	are	be	AUX
ajlm-1355	85	13	required	require	VERB
ajlm-1355	85	14	to	to	PART
ajlm-1355	85	15	optimise	optimise	VERB
ajlm-1355	85	16	the	the	DET
ajlm-1355	85	17	therapeutic	therapeutic	ADJ
ajlm-1355	85	18	approach	approach	NOUN
ajlm-1355	85	19	.	.	PUNCT
ajlm-1355	86	1	acknowledgements	acknowledgement	NOUN
ajlm-1355	86	2	thanking	thank	VERB
ajlm-1355	86	3	both	both	CCONJ
ajlm-1355	86	4	ashleigh	ashleigh	ADJ
ajlm-1355	86	5	forsman	forsman	NOUN
ajlm-1355	86	6	and	and	CCONJ
ajlm-1355	86	7	tshilidzi	tshilidzi	ADJ
ajlm-1355	86	8	dzivhani	dzivhani	PROPN
ajlm-1355	86	9	from	from	ADP
ajlm-1355	86	10	the	the	DET
ajlm-1355	86	11	somatic	somatic	ADJ
ajlm-1355	86	12	cell	cell	NOUN
ajlm-1355	86	13	genetics	genetic	NOUN
ajlm-1355	86	14	unit	unit	NOUN
ajlm-1355	86	15	(	(	PUNCT
ajlm-1355	86	16	department	department	NOUN
ajlm-1355	86	17	of	of	ADP
ajlm-1355	86	18	molecular	molecular	ADJ
ajlm-1355	86	19	medicine	medicine	NOUN
ajlm-1355	86	20	and	and	CCONJ
ajlm-1355	86	21	haematology	haematology	NOUN
ajlm-1355	86	22	,	,	PUNCT
ajlm-1355	86	23	national	national	PROPN
ajlm-1355	86	24	health	health	PROPN
ajlm-1355	86	25	laboratory	laboratory	PROPN
ajlm-1355	86	26	service	service	PROPN
ajlm-1355	86	27	,	,	PUNCT
ajlm-1355	86	28	johannesburg	johannesburg	PROPN
ajlm-1355	86	29	)	)	PUNCT
ajlm-1355	86	30	for	for	ADP
ajlm-1355	86	31	the	the	DET
ajlm-1355	86	32	analysis	analysis	NOUN
ajlm-1355	86	33	of	of	ADP
ajlm-1355	86	34	the	the	DET
ajlm-1355	86	35	fluorescence	fluorescence	NOUN
ajlm-1355	86	36	in	in	ADP
ajlm-1355	86	37	-	-	PUNCT
ajlm-1355	86	38	situ	situ	NOUN
ajlm-1355	86	39	hybridisation	hybridisation	NOUN
ajlm-1355	86	40	.	.	PUNCT
ajlm-1355	87	1	competing	compete	VERB
ajlm-1355	87	2	interests	interest	NOUN
ajlm-1355	87	3	the	the	DET
ajlm-1355	87	4	authors	author	NOUN
ajlm-1355	87	5	declare	declare	VERB
ajlm-1355	87	6	that	that	SCONJ
ajlm-1355	87	7	they	they	PRON
ajlm-1355	87	8	have	have	VERB
ajlm-1355	87	9	no	no	DET
ajlm-1355	87	10	financial	financial	ADJ
ajlm-1355	87	11	or	or	CCONJ
ajlm-1355	87	12	personal	personal	ADJ
ajlm-1355	87	13	relationships	relationship	NOUN
ajlm-1355	87	14	that	that	PRON
ajlm-1355	87	15	may	may	AUX
ajlm-1355	87	16	have	have	AUX
ajlm-1355	87	17	inappropriately	inappropriately	ADV
ajlm-1355	87	18	influenced	influence	VERB
ajlm-1355	87	19	them	they	PRON
ajlm-1355	87	20	in	in	ADP
ajlm-1355	87	21	writing	write	VERB
ajlm-1355	87	22	this	this	DET
ajlm-1355	87	23	article	article	NOUN
ajlm-1355	87	24	.	.	PUNCT
ajlm-1355	88	1	authors	author	NOUN
ajlm-1355	88	2	’	’	PART
ajlm-1355	88	3	contributions	contribution	NOUN
ajlm-1355	88	4	k.e.h	k.e.h	NOUN
ajlm-1355	88	5	.	.	PUNCT
ajlm-1355	89	1	drafted	draft	VERB
ajlm-1355	89	2	the	the	DET
ajlm-1355	89	3	manuscript	manuscript	NOUN
ajlm-1355	89	4	.	.	PUNCT
ajlm-1355	90	1	all	all	DET
ajlm-1355	90	2	authors	author	NOUN
ajlm-1355	90	3	were	be	AUX
ajlm-1355	90	4	involved	involve	VERB
ajlm-1355	90	5	in	in	ADP
ajlm-1355	90	6	the	the	DET
ajlm-1355	90	7	conceptualisation	conceptualisation	NOUN
ajlm-1355	90	8	,	,	PUNCT
ajlm-1355	90	9	structuring	structuring	NOUN
ajlm-1355	90	10	and	and	CCONJ
ajlm-1355	90	11	editing	editing	NOUN
ajlm-1355	90	12	of	of	ADP
ajlm-1355	90	13	the	the	DET
ajlm-1355	90	14	final	final	ADJ
ajlm-1355	90	15	manuscript	manuscript	NOUN
ajlm-1355	90	16	.	.	PUNCT
ajlm-1355	91	1	sources	source	NOUN
ajlm-1355	91	2	of	of	ADP
ajlm-1355	91	3	support	support	NOUN
ajlm-1355	91	4	this	this	DET
ajlm-1355	91	5	research	research	NOUN
ajlm-1355	91	6	received	receive	VERB
ajlm-1355	91	7	no	no	DET
ajlm-1355	91	8	specific	specific	ADJ
ajlm-1355	91	9	grant	grant	NOUN
ajlm-1355	91	10	from	from	ADP
ajlm-1355	91	11	any	any	DET
ajlm-1355	91	12	funding	funding	NOUN
ajlm-1355	91	13	agency	agency	NOUN
ajlm-1355	91	14	in	in	ADP
ajlm-1355	91	15	the	the	DET
ajlm-1355	91	16	public	public	ADJ
ajlm-1355	91	17	,	,	PUNCT
ajlm-1355	91	18	commercial	commercial	ADJ
ajlm-1355	91	19	or	or	CCONJ
ajlm-1355	91	20	not	not	PART
ajlm-1355	91	21	-	-	PUNCT
ajlm-1355	91	22	for	for	ADP
ajlm-1355	91	23	-	-	PUNCT
ajlm-1355	91	24	profit	profit	NOUN
ajlm-1355	91	25	sectors	sector	NOUN
ajlm-1355	91	26	.	.	PUNCT
ajlm-1355	92	1	data	datum	NOUN
ajlm-1355	92	2	availability	availability	NOUN
ajlm-1355	92	3	data	datum	NOUN
ajlm-1355	92	4	sharing	sharing	NOUN
ajlm-1355	92	5	is	be	AUX
ajlm-1355	92	6	not	not	PART
ajlm-1355	92	7	applicable	applicable	ADJ
ajlm-1355	92	8	to	to	ADP
ajlm-1355	92	9	this	this	DET
ajlm-1355	92	10	article	article	NOUN
ajlm-1355	92	11	as	as	SCONJ
ajlm-1355	92	12	no	no	DET
ajlm-1355	92	13	new	new	ADJ
ajlm-1355	92	14	data	datum	NOUN
ajlm-1355	92	15	were	be	AUX
ajlm-1355	92	16	created	create	VERB
ajlm-1355	92	17	or	or	CCONJ
ajlm-1355	92	18	analysed	analyse	VERB
ajlm-1355	92	19	in	in	ADP
ajlm-1355	92	20	this	this	DET
ajlm-1355	92	21	study	study	NOUN
ajlm-1355	92	22	.	.	PUNCT
ajlm-1355	93	1	disclaimer	disclaimer	VERB
ajlm-1355	93	2	the	the	DET
ajlm-1355	93	3	views	view	NOUN
ajlm-1355	93	4	and	and	CCONJ
ajlm-1355	93	5	opinions	opinion	NOUN
ajlm-1355	93	6	expressed	express	VERB
ajlm-1355	93	7	in	in	ADP
ajlm-1355	93	8	this	this	DET
ajlm-1355	93	9	article	article	NOUN
ajlm-1355	93	10	are	be	AUX
ajlm-1355	93	11	those	those	PRON
ajlm-1355	93	12	of	of	ADP
ajlm-1355	93	13	the	the	DET
ajlm-1355	93	14	authors	author	NOUN
ajlm-1355	93	15	and	and	CCONJ
ajlm-1355	93	16	do	do	AUX
ajlm-1355	93	17	not	not	PART
ajlm-1355	93	18	necessarily	necessarily	ADV
ajlm-1355	93	19	reflect	reflect	VERB
ajlm-1355	93	20	the	the	DET
ajlm-1355	93	21	official	official	ADJ
ajlm-1355	93	22	policy	policy	NOUN
ajlm-1355	93	23	or	or	CCONJ
ajlm-1355	93	24	position	position	NOUN
ajlm-1355	93	25	of	of	ADP
ajlm-1355	93	26	any	any	DET
ajlm-1355	93	27	affiliated	affiliated	ADJ
ajlm-1355	93	28	agency	agency	NOUN
ajlm-1355	93	29	of	of	ADP
ajlm-1355	93	30	the	the	DET
ajlm-1355	93	31	author	author	NOUN
ajlm-1355	93	32	.	.	PUNCT
ajlm-1355	94	1	references	reference	NOUN
ajlm-1355	94	2	navid	navid	PROPN
ajlm-1355	94	3	f	f	PROPN
ajlm-1355	94	4	,	,	PUNCT
ajlm-1355	94	5	mosijczuk	mosijczuk	PROPN
ajlm-1355	94	6	ad	ad	NOUN
ajlm-1355	94	7	,	,	PUNCT
ajlm-1355	94	8	head	head	NOUN
ajlm-1355	94	9	dr	dr	PROPN
ajlm-1355	94	10	,	,	PUNCT
ajlm-1355	94	11	et	et	PROPN
ajlm-1355	95	1	al	al	PROPN
ajlm-1355	95	2	.	.	PROPN
ajlm-1355	95	3	acute	acute	PROPN
ajlm-1355	95	4	lymphoblastic	lymphoblastic	ADJ
ajlm-1355	95	5	leukemia	leukemia	NOUN
ajlm-1355	95	6	with	with	ADP
ajlm-1355	95	7	the	the	DET
ajlm-1355	95	8	(	(	PUNCT
ajlm-1355	95	9	8;14)(q24;q32	8;14)(q24;q32	NUM
ajlm-1355	95	10	)	)	PUNCT
ajlm-1355	95	11	translocation	translocation	NOUN
ajlm-1355	95	12	and	and	CCONJ
ajlm-1355	95	13	fab	fab	PROPN
ajlm-1355	95	14	l3	l3	PROPN
ajlm-1355	95	15	morphology	morphology	NOUN
ajlm-1355	95	16	associated	associate	VERB
ajlm-1355	95	17	with	with	ADP
ajlm-1355	95	18	a	a	DET
ajlm-1355	95	19	b	b	NOUN
ajlm-1355	95	20	-	-	PUNCT
ajlm-1355	95	21	precursor	precursor	NOUN
ajlm-1355	95	22	immunophenotype	immunophenotype	NOUN
ajlm-1355	95	23	:	:	PUNCT
ajlm-1355	95	24	the	the	DET
ajlm-1355	95	25	pediatric	pediatric	ADJ
ajlm-1355	95	26	oncology	oncology	NOUN
ajlm-1355	95	27	group	group	NOUN
ajlm-1355	95	28	experience	experience	NOUN
ajlm-1355	95	29	.	.	PUNCT
ajlm-1355	96	1	leukemia	leukemia	NOUN
ajlm-1355	96	2	.	.	PUNCT
ajlm-1355	97	1	1999;13(1):135–141	1999;13(1):135–141	X
ajlm-1355	97	2	.	.	X
ajlm-1355	97	3	https://doi.org/10.1038/sj.leu.2401244	https://doi.org/10.1038/sj.leu.2401244	PROPN
ajlm-1355	97	4	swerdlow	swerdlow	PROPN
ajlm-1355	97	5	sh	sh	PROPN
ajlm-1355	97	6	,	,	PUNCT
ajlm-1355	97	7	campo	campo	PROPN
ajlm-1355	97	8	e	e	PROPN
ajlm-1355	97	9	,	,	PUNCT
ajlm-1355	97	10	pileri	pileri	PROPN
ajlm-1355	97	11	sa	sa	PROPN
ajlm-1355	97	12	,	,	PUNCT
ajlm-1355	97	13	et	et	PROPN
ajlm-1355	97	14	al	al	PROPN
ajlm-1355	97	15	.	.	PUNCT
ajlm-1355	98	1	the	the	DET
ajlm-1355	98	2	2016	2016	NUM
ajlm-1355	98	3	revision	revision	NOUN
ajlm-1355	98	4	of	of	ADP
ajlm-1355	98	5	the	the	DET
ajlm-1355	98	6	world	world	PROPN
ajlm-1355	98	7	health	health	PROPN
ajlm-1355	98	8	organization	organization	NOUN
ajlm-1355	98	9	classification	classification	NOUN
ajlm-1355	98	10	of	of	ADP
ajlm-1355	98	11	lymphoid	lymphoid	ADJ
ajlm-1355	98	12	neoplasms	neoplasm	NOUN
ajlm-1355	98	13	.	.	PUNCT
ajlm-1355	99	1	blood	blood	NOUN
ajlm-1355	99	2	.	.	PUNCT
ajlm-1355	100	1	2016;127(20):2375–2390	2016;127(20):2375–2390	X
ajlm-1355	100	2	.	.	PUNCT
ajlm-1355	101	1	https://doi.org/10.1182/blood-2016-01-643569	https://doi.org/10.1182/blood-2016-01-643569	PROPN
ajlm-1355	101	2	shiratori	shiratori	PROPN
ajlm-1355	101	3	s	s	PROPN
ajlm-1355	101	4	,	,	PUNCT
ajlm-1355	101	5	kondo	kondo	PROPN
ajlm-1355	101	6	t	t	PROPN
ajlm-1355	101	7	,	,	PUNCT
ajlm-1355	101	8	fujisawa	fujisawa	PROPN
ajlm-1355	101	9	s	s	PART
ajlm-1355	101	10	,	,	PUNCT
ajlm-1355	101	11	et	et	PROPN
ajlm-1355	101	12	al	al	PROPN
ajlm-1355	101	13	.	.	PROPN
ajlm-1355	102	1	c	c	X
ajlm-1355	102	2	-	-	PUNCT
ajlm-1355	102	3	myc	myc	NOUN
ajlm-1355	102	4	rearrangement	rearrangement	NOUN
ajlm-1355	102	5	in	in	ADP
ajlm-1355	102	6	b	b	NOUN
ajlm-1355	102	7	-	-	PUNCT
ajlm-1355	102	8	cell	cell	NOUN
ajlm-1355	102	9	lymphoblastic	lymphoblastic	ADJ
ajlm-1355	102	10	lymphoma	lymphoma	NOUN
ajlm-1355	102	11	with	with	ADP
ajlm-1355	102	12	the	the	DET
ajlm-1355	102	13	involvement	involvement	NOUN
ajlm-1355	102	14	of	of	ADP
ajlm-1355	102	15	multiple	multiple	ADJ
ajlm-1355	102	16	extranodal	extranodal	NOUN
ajlm-1355	102	17	lesions	lesion	NOUN
ajlm-1355	102	18	.	.	PUNCT
ajlm-1355	103	1	leuk	leuk	NOUN
ajlm-1355	103	2	lymphoma	lymphoma	NOUN
ajlm-1355	103	3	.	.	PUNCT
ajlm-1355	104	1	2011;52(4):716–718	2011;52(4):716–718	X
ajlm-1355	104	2	.	.	PUNCT
ajlm-1355	105	1	https://doi.org/10.3109/10428194.2010.551158	https://doi.org/10.3109/10428194.2010.551158	PROPN
ajlm-1355	105	2	meznarich	meznarich	PROPN
ajlm-1355	105	3	j	j	PROPN
ajlm-1355	105	4	,	,	PUNCT
ajlm-1355	105	5	miles	miles	PROPN
ajlm-1355	105	6	r	r	NOUN
ajlm-1355	105	7	,	,	PUNCT
ajlm-1355	105	8	paxton	paxton	PROPN
ajlm-1355	105	9	cn	cn	PROPN
ajlm-1355	105	10	,	,	PUNCT
ajlm-1355	105	11	afify	afify	VERB
ajlm-1355	105	12	z.	z.	PROPN
ajlm-1355	105	13	pediatric	pediatric	PROPN
ajlm-1355	105	14	b	b	PROPN
ajlm-1355	105	15	-	-	PUNCT
ajlm-1355	105	16	cell	cell	NOUN
ajlm-1355	105	17	lymphoma	lymphoma	NOUN
ajlm-1355	105	18	with	with	ADP
ajlm-1355	105	19	lymphoblastic	lymphoblastic	ADJ
ajlm-1355	105	20	morphology	morphology	NOUN
ajlm-1355	105	21	,	,	PUNCT
ajlm-1355	105	22	tdt	tdt	PROPN
ajlm-1355	105	23	expression	expression	NOUN
ajlm-1355	105	24	,	,	PUNCT
ajlm-1355	105	25	myc	myc	NOUN
ajlm-1355	105	26	rearrangement	rearrangement	NOUN
ajlm-1355	105	27	,	,	PUNCT
ajlm-1355	105	28	and	and	CCONJ
ajlm-1355	105	29	features	feature	VERB
ajlm-1355	105	30	overlapping	overlap	VERB
ajlm-1355	105	31	with	with	ADP
ajlm-1355	105	32	burkitt	burkitt	ADJ
ajlm-1355	105	33	lymphoma	lymphoma	NOUN
ajlm-1355	105	34	.	.	PUNCT
ajlm-1355	106	1	pediatr	pediatr	ADJ
ajlm-1355	106	2	blood	blood	NOUN
ajlm-1355	106	3	cancer	cancer	NOUN
ajlm-1355	106	4	.	.	PUNCT
ajlm-1355	107	1	2016;63(5):938–940	2016;63(5):938–940	X
ajlm-1355	107	2	.	.	PUNCT
ajlm-1355	108	1	https://doi.org/10.1002/pbc.25907	https://doi.org/10.1002/pbc.25907	PROPN
ajlm-1355	108	2	sakaguchi	sakaguchi	PROPN
ajlm-1355	109	1	k	k	PROPN
ajlm-1355	109	2	,	,	PUNCT
ajlm-1355	109	3	imamura	imamura	PROPN
ajlm-1355	109	4	t	t	PROPN
ajlm-1355	109	5	,	,	PUNCT
ajlm-1355	109	6	ishimaru	ishimaru	PROPN
ajlm-1355	109	7	s	s	PROPN
ajlm-1355	109	8	,	,	PUNCT
ajlm-1355	109	9	et	et	PROPN
ajlm-1355	109	10	al	al	PROPN
ajlm-1355	109	11	.	.	PROPN
ajlm-1355	110	1	nationwide	nationwide	ADJ
ajlm-1355	110	2	study	study	NOUN
ajlm-1355	110	3	of	of	ADP
ajlm-1355	110	4	pediatric	pediatric	ADJ
ajlm-1355	110	5	b	b	NOUN
ajlm-1355	110	6	-	-	PUNCT
ajlm-1355	110	7	cell	cell	NOUN
ajlm-1355	110	8	precursor	precursor	NOUN
ajlm-1355	110	9	acute	acute	NOUN
ajlm-1355	110	10	lymphoblastic	lymphoblastic	ADJ
ajlm-1355	110	11	leukemia	leukemia	NOUN
ajlm-1355	110	12	with	with	ADP
ajlm-1355	110	13	chromosome	chromosome	NOUN
ajlm-1355	110	14	8q24	8q24	NUM
ajlm-1355	110	15	/	/	SYM
ajlm-1355	110	16	myc	myc	NOUN
ajlm-1355	110	17	rearrangement	rearrangement	NOUN
ajlm-1355	110	18	in	in	ADP
ajlm-1355	110	19	japan	japan	PROPN
ajlm-1355	110	20	.	.	PUNCT
ajlm-1355	111	1	pediatric	pediatric	ADJ
ajlm-1355	111	2	blood	blood	NOUN
ajlm-1355	111	3	cancer	cancer	NOUN
ajlm-1355	111	4	.	.	PUNCT
ajlm-1355	112	1	2020;67(7):e28341	2020;67(7):e28341	NUM
ajlm-1355	112	2	.	.	PUNCT
ajlm-1355	113	1	https://doi.org/10.1002/pbc.28341	https://doi.org/10.1002/pbc.28341	ADJ
ajlm-1355	113	2	glencross	glencross	ADJ
ajlm-1355	113	3	dk	dk	PROPN
ajlm-1355	113	4	.	.	PROPN
ajlm-1355	113	5	flow	flow	PROPN
ajlm-1355	113	6	cytometry	cytometry	NOUN
ajlm-1355	113	7	in	in	ADP
ajlm-1355	113	8	diagnostic	diagnostic	ADJ
ajlm-1355	113	9	haematopathology	haematopathology	NOUN
ajlm-1355	113	10	.	.	PUNCT
ajlm-1355	114	1	johannesburg	johannesburg	PROPN
ajlm-1355	114	2	:	:	PUNCT
ajlm-1355	114	3	university	university	NOUN
ajlm-1355	114	4	of	of	ADP
ajlm-1355	114	5	the	the	DET
ajlm-1355	114	6	witwatersrand	witwatersrand	NOUN
ajlm-1355	114	7	;	;	PUNCT
ajlm-1355	114	8	1992	1992	NUM
ajlm-1355	114	9	.	.	PUNCT
ajlm-1355	115	1	patte	patte	PROPN
ajlm-1355	115	2	c	c	PROPN
ajlm-1355	115	3	,	,	PUNCT
ajlm-1355	115	4	auperin	auperin	ADV
ajlm-1355	115	5	a	a	PRON
ajlm-1355	115	6	,	,	PUNCT
ajlm-1355	115	7	gerrard	gerrard	PROPN
ajlm-1355	115	8	m	m	PROPN
ajlm-1355	115	9	,	,	PUNCT
ajlm-1355	115	10	et	et	PROPN
ajlm-1355	115	11	al	al	PROPN
ajlm-1355	115	12	.	.	PROPN
ajlm-1355	115	13	results	result	NOUN
ajlm-1355	115	14	of	of	ADP
ajlm-1355	115	15	the	the	DET
ajlm-1355	115	16	randomized	randomized	ADJ
ajlm-1355	115	17	international	international	ADJ
ajlm-1355	115	18	fab	fab	NOUN
ajlm-1355	115	19	/	/	SYM
ajlm-1355	115	20	lmb96	lmb96	PROPN
ajlm-1355	115	21	trial	trial	NOUN
ajlm-1355	115	22	for	for	ADP
ajlm-1355	115	23	intermediate	intermediate	ADJ
ajlm-1355	115	24	risk	risk	NOUN
ajlm-1355	115	25	b	b	NOUN
ajlm-1355	115	26	-	-	PUNCT
ajlm-1355	115	27	cell	cell	NOUN
ajlm-1355	115	28	non	non	ADJ
ajlm-1355	115	29	-	-	ADJ
ajlm-1355	115	30	hodgkin	hodgkin	ADJ
ajlm-1355	115	31	lymphoma	lymphoma	NOUN
ajlm-1355	115	32	in	in	ADP
ajlm-1355	115	33	children	child	NOUN
ajlm-1355	115	34	and	and	CCONJ
ajlm-1355	115	35	adolescents	adolescent	NOUN
ajlm-1355	115	36	:	:	PUNCT
ajlm-1355	115	37	it	it	PRON
ajlm-1355	115	38	is	be	AUX
ajlm-1355	115	39	possible	possible	ADJ
ajlm-1355	115	40	to	to	PART
ajlm-1355	115	41	reduce	reduce	VERB
ajlm-1355	115	42	treatment	treatment	NOUN
ajlm-1355	115	43	for	for	ADP
ajlm-1355	115	44	the	the	DET
ajlm-1355	115	45	early	early	ADJ
ajlm-1355	115	46	responding	respond	VERB
ajlm-1355	115	47	patients	patient	NOUN
ajlm-1355	115	48	.	.	PUNCT
ajlm-1355	116	1	blood	blood	NOUN
ajlm-1355	116	2	.	.	PUNCT
ajlm-1355	117	1	2007;109(7):2773–2780	2007;109(7):2773–2780	NUM
ajlm-1355	117	2	.	.	PUNCT
ajlm-1355	118	1	https://doi.org/10.1182/blood-2006-07-036673	https://doi.org/10.1182/blood-2006-07-036673	PROPN
ajlm-1355	118	2	mccaffrey	mccaffrey	PROPN
ajlm-1355	118	3	r	r	PROPN
ajlm-1355	118	4	,	,	PUNCT
ajlm-1355	118	5	harrison	harrison	PROPN
ajlm-1355	118	6	ta	ta	PROPN
ajlm-1355	118	7	,	,	PUNCT
ajlm-1355	118	8	parkman	parkman	PROPN
ajlm-1355	118	9	r	r	PROPN
ajlm-1355	118	10	,	,	PUNCT
ajlm-1355	118	11	baltimore	baltimore	PROPN
ajlm-1355	118	12	d.	d.	PROPN
ajlm-1355	118	13	terminal	terminal	PROPN
ajlm-1355	118	14	deoxynucleotidyl	deoxynucleotidyl	NOUN
ajlm-1355	118	15	transferase	transferase	NOUN
ajlm-1355	118	16	activity	activity	NOUN
ajlm-1355	118	17	in	in	ADP
ajlm-1355	118	18	human	human	ADJ
ajlm-1355	118	19	leukemic	leukemic	ADJ
ajlm-1355	118	20	cells	cell	NOUN
ajlm-1355	118	21	and	and	CCONJ
ajlm-1355	118	22	in	in	ADP
ajlm-1355	118	23	normal	normal	ADJ
ajlm-1355	118	24	human	human	ADJ
ajlm-1355	118	25	thymocytes	thymocyte	NOUN
ajlm-1355	118	26	.	.	PUNCT
ajlm-1355	119	1	n	n	PRON
ajlm-1355	119	2	engl	engl	PROPN
ajlm-1355	119	3	j	j	PROPN
ajlm-1355	119	4	med	med	PROPN
ajlm-1355	119	5	.	.	PUNCT
ajlm-1355	120	1	1975;292(15):775–780	1975;292(15):775–780	X
ajlm-1355	120	2	.	.	PUNCT
ajlm-1355	120	3	https://doi.org/10.1056/nejm197504102921504	https://doi.org/10.1056/nejm197504102921504	PROPN
ajlm-1355	120	4	wagener	wagener	ADJ
ajlm-1355	120	5	r	r	NOUN
ajlm-1355	120	6	,	,	PUNCT
ajlm-1355	120	7	lópez	lópez	NOUN
ajlm-1355	120	8	c	c	NOUN
ajlm-1355	120	9	,	,	PUNCT
ajlm-1355	120	10	kleinheinz	kleinheinz	PROPN
ajlm-1355	120	11	k	k	PROPN
ajlm-1355	120	12	,	,	PUNCT
ajlm-1355	120	13	et	et	PROPN
ajlm-1355	120	14	al	al	PROPN
ajlm-1355	120	15	.	.	PUNCT
ajlm-1355	120	16	ig	ig	PROPN
ajlm-1355	120	17	-	-	PUNCT
ajlm-1355	120	18	myc	myc	NOUN
ajlm-1355	120	19	(	(	PUNCT
ajlm-1355	120	20	+	+	NOUN
ajlm-1355	120	21	)	)	PUNCT
ajlm-1355	120	22	neoplasms	neoplasm	NOUN
ajlm-1355	120	23	with	with	ADP
ajlm-1355	120	24	precursor	precursor	NOUN
ajlm-1355	120	25	b	b	NOUN
ajlm-1355	120	26	-	-	PUNCT
ajlm-1355	120	27	cell	cell	NOUN
ajlm-1355	120	28	phenotype	phenotype	NOUN
ajlm-1355	120	29	are	be	AUX
ajlm-1355	120	30	molecularly	molecularly	ADV
ajlm-1355	120	31	distinct	distinct	ADJ
ajlm-1355	120	32	from	from	ADP
ajlm-1355	120	33	burkitt	burkitt	ADJ
ajlm-1355	120	34	lymphomas	lymphoma	NOUN
ajlm-1355	120	35	.	.	PUNCT
ajlm-1355	121	1	blood	blood	NOUN
ajlm-1355	121	2	.	.	PUNCT
ajlm-1355	122	1	2018;132(21):2280–2285	2018;132(21):2280–2285	NUM
ajlm-1355	122	2	.	.	PUNCT
ajlm-1355	123	1	https://doi.org/10.1182/blood-2018-03-842088	https://doi.org/10.1182/blood-2018-03-842088	NUM